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ABSTRACT
The Effects of Poor Maternal Nutrition on Offspring Muscle Metabolism
Dominique E. Martin
University of Connecticut, 2018

Poor maternal nutrition during gestation alters offspring muscle composition, fiber
number, postnatal growth, and stem cell function. Additionally, poor maternal nutrition impacts
offspring whole body and stem cell metabolism. We hypothesized that over- or restricted-feeding
during gestation would alter muscle myoblast metabolism as well as offspring Longissimus dorsi
muscle (LD) metabolome. Pregnant Western White-faced ewes (n = 47) were individually fed
60% (RES), 100% (CON), or 140% (OVER) of NRC requirements starting at d 30.2 ± 0.2 of
gestation. At d 90 and 135 of gestation, ewes were euthanized for fetal muscle collection.
Another group of ewes were allowed to lamb and offspring were necropsied within 24 h of birth
for offspring serum and muscle sample collection. C2C12 myoblasts were cultured in fetal serum
to determine effects of poor maternal nutrition on cell proliferation, differentiation, and
metabolism. Glycolytic function and mitochondrial respiration of C2C12 cells cultured in serum
from CON, RES, and OVER lambs at birth were analyzed using the Seahorse Bioscience XF
analyzer. Cell culture data were analyzed as a completely randomized design using PROC
MIXED in SAS with main effects and interaction of gender and maternal diet. Mass
spectrophotometry of LD samples (n = 8 fetuses per treatment per time point) identified 612
metabolites. Metabolome data were analyzed by ANOVA for main effects of treatment, time
point, and their interaction. There was no observed effect (P ≤ 0.05) of maternal diet on C2C12
proliferation, fusion index, or glycolytic function. Proton leak was increased in C2C12 cells
cultured in RES serum compared with CON (P = 0.04). For the metabolome analysis, compared
with CON, maternal over-feeding altered metabolites in 63 pathways and maternal restrictedix

feeding altered metabolites in 56 pathways (P ≤ 0.05) in the offspring. Both maternal restrictedand over-feeding altered offspring metabolites in each of the 8 major metabolic pathways
including amino acid, peptide, carbohydrate, energy, lipid, nucleotide, cofactors and vitamins,
and xenobiotics. Maternal over-feeding decreased concentrations of 1 phosphatidylcholine (PC)
metabolite at d 90, 2 PC metabolites at d 135, and 4 PC metabolites at birth compared with CON
(P ≤ 0.05). Additionally, at d 135, maternal over-feeding increased 1 phosphatidylethanolamine
(PE) metabolite while reducing 10 PE metabolites at birth compared with CON (P ≤ 0.05).
Offspring from over-fed ewes had decreased concentrations of 12 lysolipids at birth compared
with CON (P ≤ 0.05). Maternal restricted-feeding increased expression of reduced glutathione
3.07-fold at d 90 (P = 0.008), whereas at d 135, oxidized glutathione was decreased 21%
compared with CON (P = 0.03). Overall, poor maternal nutrition during gestation alters offspring
metabolism. Specifically, maternal over-feeding may promote increased lipid oxidation in
offspring muscle, which may predispose offspring to altered lipid utilization and storage
postnatally. Maternal restricted-feeding resulted in alterations in glutathione metabolism,
potentially indicative of changes to redox status in these offspring.

x

REVIEW OF LITERATURE
Introduction
Despite advancements in production techniques and management, livestock commonly
face instances of restricted- and over-feeding (Thomas and Kott, 1995; Everett-Hincks and
Dodds, 2007: Hoffman et al, 2017). Restricted nutrition can often arise due to different
management practices as well as variations in feed quality (Thomas and Kott, 1995; EverettHincks and Dodds, 2007). The quality of feed can be impacted by seasonal weather changes
and/or limited forage availability or intake (Thomas and Kott, 1995; Hoffman et al., 2017).
Production of sheep on a forage-based system is common, subjecting the animals to climate and
forage fluctuations. Ewes are short-day breeders and typically gestate during the winter months
when forage quality and abundance on the range is limited (Wu et al., 2004). Therefore, ewes
raised on the range are susceptible to reduced forage quality and intake and often receive below
50% of NRC nutritional requirements during the winter months in the Western United States
(Thomas and Kott, 1995). Similarly, instances of over-nutrition can result due to different
management and production systems of ruminant animals. Management systems in the Northeast
or at Land Grant universities may provide more than sufficient nutrients, resulting in increased
feed intake and over-conditioning during the winter months (Jobgen et al., 2008). Additionally,
the practice of flushing, which is increasing the amount of feed before conception to encourage
superovulation in ewes (National Research Council, 1985), leads to instances of over-nutrition.
Other management practices also affect sheep productivity. The practice of selecting for
fecundity, or increased offspring number, has increased over the last four decades (EverettHincks and Dodds, 2007). This affects lamb survival since maternal nutrients and resources have
to be partitioned to more offspring. Additionally, lamb mortality is greater in twin- and tripletborn lambs compared with singletons (Johnson et al., 1982; Hinch et al., 1983; Scales et al.,
1

1986; Hall et al., 1988). Although the increased mortality rate could be due to a variety of
factors, maternal nutrition is an important contributor. Scales et al. (1986) demonstrated that
when ewes bearing multiple offspring were offered additional feed during late pregnancy, lamb
mortality was reduced.
Proper fetal growth and development is dependent on maternal nutritional intake during
gestation. Maternal nutrition is the diet a mother consumes before pregnancy, during gestation,
and continued through lactation (American Journal of Public Health, 1973). Poor maternal
nutrition can negatively impact offspring growth and development and is defined as inadequate
or increased nutrient availability during gestation (Hoffman et al., 2017). Both restricted- and
over-feeding during gestation can result in programming of the offspring, which can lead to
alterations in body size and birth weight of offspring, as well as impaired muscle growth,
changes in adiposity, and altered metabolism (Hoffman et al., 2017). Additionally, poor
maternal nutrition has been shown to impair overall offspring growth and health. Both
epidemiological and livestock studies have demonstrated that restricted- and over-feeding have
long-lasting and detrimental effects on offspring productivity and health (Hales and Barker,
2001; Wu et al., 2004). The Thrifty Phenotype Hypothesis, proposed by Hales and Barker
(2001), is a classic example of programming. The hypothesis states when there is a period of
maternal nutrient restriction during pregnancy, the developing fetus is exposed to inadequate
nutrition, which results in programming so that the fetus is prepared to survive in an environment
with limited nutrient supply later in life (Hales and Barker, 2001).
Muscle is a tissue that is susceptible to programming in response to poor maternal
nutrition (Reed et al., 2014). Muscle growth is a tightly regulated process controlled by
numerous intrinsic and extrinsic factors. The majority of muscle development occurs during
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gestation. During this time, animals undergo primary and secondary myogenesis to form muscle
fibers, and the total number of muscle fibers an animal will have throughout the entirety of their
life is set before birth (Rowe and Goldspink et al., 1969; Beerman et al., 1978; Wigmore and
Stickland et al., 1983). After birth, the muscle fibers undergo hypertrophy where they increase in
size but not in number (Rowe and Goldspink et al., 1969; Beerman et al., 1978; Wigmore and
Stickland et al., 1983; White et al. 2010). Thus, the period of gestation is crucial for proper
muscle development, and this tissue is susceptible to programming. Both meat quality, defined
by factors such as tenderness, juiciness, and flavor, as well as meay quantity are important
factors in marketable animals, and producers are interested in efficiently producing animals with
the greatest amounts of high quality meat. The muscle itself is an extremely important tissue to
the animal since it serves as an amino acid reservoir and is involved in metabolism (Brown et al.,
2014; Wolfe, 2006).
Changes in muscle quantity and quality in response to poor maternal nutrition could be
detrimental to production, efficiency, and animal health. Therefore, it is important to understand
the factors and mechanisms that contribute to the programming of muscle. Production of healthy
and efficient animals is necessary due to the rising demand quality protein sources. By 2050, the
global population is expected to increase by 30% and reach 9.7 billion people (United Nations,
2015). Livestock significantly contribute to the global food economy by providing dairy, egg,
and meat products. The increase in population will result in an increased demand for animal
products (Thorton 2010), and producers will have to meet this demand through more efficient
animal production. Since poor maternal nutrition can have detrimental effects on livestock
production, and therefore efficiency, it is essential to better understand the effects of
programming.
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Prenatal Muscle Development
Myoblasts are first recruited from the mesenchyme and differentiate into muscle
progenitor cells (MPCs; Pittenger et al., 1999; Biressi et al., 2007). Proliferating MPCs coexpress transcription factors Paired box 3 (Pax3) and 7 (Pax7; Biressi et al., 2007). In particular,
Pax7 is an early marker of MPCs and is essential in maintaining these cells in a proliferative
state (Zammit et al., 2016). Downregulation of Pax7 before differentiation is essential for
progression through myogenesis (Zammit et al., 2006; Yablonka-Ruveni et al., 2008). Muscle
progenitor cells will differentiate into muscle fibers through appropriate temporal expression of
myogenic regulatory factors (MRFs), which drive the processes of proliferation and
differentiation. These include myogenic factor 5 (MYF5), myogenic differentiation factor 1
(MyoD), MRF4, and myogenin (Yablonka-Reuveni and Rivera, 1994). Myogenic regulatory
factors drive the process of differentiation and are expressed in a sequential order to regulate
muscle fiber formation (Berkes and Tapscott, 2005; Braun and Guatel, 2011). These four factors
regulate myogenesis to form myotubes which mature into myofibers (Rehfeldt et al., 2004).
Specifically, Myf5 and MyoD commit early progenitor cells to the muscle cell type. As
differentiation proceeds, MyoD binds to myostatin, contributing to the withdrawal of the
myoblast from the cell cycle along with the increased expression of myogenin (Spiller et al.,
2002; Singh and Dilworth, 2013). Myogenin and MRF4 later allow myoblasts to fuse and
differentiate into muscle fibers (Rehfeldt et al., 2004). Myogenin and MRF4 target proteins that
regulate the switch from proliferation to differentiation including retinoblastoma protein (RB),
which inhibits cell cycle progression, and Cyclin D1 and cyclin dependent kinase-4 (CDK4),
which regulate the cell cycle (Spiller et al., 2002).
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Differentiation occurs in several waves, which generate primary and secondary fibers,
and supports hypertrophy. The initial stage is primary myogenesis, where MPCs migrate and
fuse before innervation, forming primary myofibers (Beerman et al., 1978). The second stage is
termed secondary myogenesis and is dependent on innervation. Secondary fibers are derived
from MPCs, which are originally maintained in a proliferating and undifferentiated state
(Beerman et al., 1978). These MPCs then differentiate into myoblasts and fuse adjacent to
primary myofibers to form secondary myofibers (Beerman et al., 1978). Myogenesis in sheep
begins around d 20 of gestation and is completed between d 80 and 125 depending on the muscle
(Ashmore et al., 1972, Fahey et al., 2005). Since all of the muscle fibers in the fetus are formed
during gestation, there is no net increase in fiber number after birth, only fiber size (Rowe and
Goldspink et al., 1969; Glore and Layman, 1983; Wigmore and Stickland et al., 1983; Nissen et
al., 2003; Zhu et al., 2006; Rehfeldt et al., 2011).
Establishment of skeletal muscle fiber type occurs during gestation (Phillips et al., 1986;
Condon et al., 1990; Pette and Staron, 2001). Primary myofibers mainly express slow myosin
heavy chain isoforms whereas secondary myofibers express fast myosin heavy chain isoforms
which mature into Type II fibers (Pin et al., 2002). Fiber type determination occurs at the
myoblast stage before fusion and myofiber formation. Different factors including myoblast
lineage and innervation determine the muscle fiber type (DiMario and Stockdale, 1997).
However, fiber types can switch due to various factors such as changes in insulin metabolism
(Ryder et al., 2003), hormones (Staron et al., 2000), exercise (Henriksson 1992; Booth and
Baldwin 1996), or the natural switch from embryonic to adult phenotypes (Whalen et al., 1984;
Agbulut et al., 2003). This means that skeletal muscle fibers are capable of responding to altered
functional and metabolic demands by changing their fiber type (Pette and Staron, 2001).

5

Postnatal Muscle Growth
Muscle fibers continue to increase in size postnatally until maturity. During prenatal
myogenesis, a portion of myogenic precursor cells remain undifferentiated in a quiescent state
adjacent to the myofibers, allowing them to contribute to postnatal growth (Hawke and Garry,
2001). At birth, these MPCs, termed satellite cells, account for up to 30% of total myofiber
nuclei (Yin et al., 2013). In postnatal animals, satellite cells compose approximately 3 to 6% of
total muscle nuclei (Yin et al., 2013). The increased satellite cell populations in early life
contribute to early postnatal hypertrophy and become incorporated into the growing myofiber
(Moss et al., 1971). Satellite cells are mononucleated and located between the basal lamina and
the sarcolemma in the muscle (Moss and Leblond, 1971). Satellite cells possess their own plasma
membrane, separate from membrane of the myofibers (Scharner et al., 2011). Satellite cells are
distinct from general muscle nuclei, and distinguished by specific markers such as the
transcription marker Pax7. They can also be identified by surface markers such as N-CAM, Mcadherin, and CD34 (Biressi et al., 2010). In mature animals, the satellite cells are usually
quiescent except for times of injury, growth, or repair (Aloisi et al., 1973). Satellite cells are
activated by several factors such as growth factors, production of sphingosine-1-phosphate, and
mitogens (Bischoff, 1986; Kästner et al., 2000; Clemmons, 2009). When satellite cells are
activated, their genetic expression changes, allowing for the upregulation of MRfs such as MyoD
and myogenin (Pallafacchina et al., 2010). Satellite cells contribute to muscle mass by
undergoing asymmetric division. In this process, a portion of the cells differentiate into
myoblasts and contribute to the growing muscle fiber. The other portion of the population
consists of undifferentiated cells which can replenish the quiescent satellite cell population
(Biressi et al., 2010).
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Factors Regulating Muscle Development
Hormones and Growth Factors
Hormones and growth factors have important roles in muscle development. For example,
growth hormone (GH), in conjunction with insulin-like growth factor 1 (IGF-1), regulates
postnatal muscle growth by increasing muscle mass and decreasing adiposity (Velloso et al.,
2008). The liver is primarily responsible for IGF-1 production, which is stimulated by GH
release. For example, GH administration upregulated IGF-1 mRNA as well as protein in the liver
(Matthews et al., 1986). There are also six IGF binding proteins (IGFBPs) that help modulate
IGF activity in the tissues (Parker et al., 1998). When the GH/IGF axis is impaired, muscle
growth is hindered (Baum et al., 1996; Sotiropoulos et al., 2006; Mavalli et al., 2010). Research
demonstrates that when mice are lacking a GH receptor, they have decreased muscle mass and
improper growth of myofibers (Baum et al., 1996; Sotiropoulos et al., 2006). The mice lacking
the GH receptor also exhibit a reduction in circulating IGF-1. (Sotiropoulos et al., 2006). In
vitro, GH stimulates the proliferation of MPCs and fusion of myoblasts via the activation of IGF1 (Mavalli et al., 2010). Other hormones such as testosterone can influence muscle hypertrophy,
whereas increased concentrations of corticosterone may cause atrophy (Crowley and Matt et al.,
1996). Growth factors, such as fibroblast growth factor (FGF), can also affect muscle growth and
development. During gestation, the FGF family is expressed in the mesoderm, where FGFs have
a vital role in the outgrowth of limbs (Olwin et al., 1994). The FGF family of proteins also is
involved in regulating the balance between proliferation and differentiation of MPCs by
activating MyoD (Hauschka et al., 1992).

Amino Acids and the mTOR Pathway
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A large portion of muscle hypertrophy takes place during late prenatal and early postnatal
life, when fibers are rapidly growing, but this process continues throughout adulthood (Davis and
Fiorotto, 2009). Protein accretion contributes to muscle hypertrophy and occurs during gestation
and in postnatal growth. Protein accretion occurs when the rate of protein synthesis exceeds the
rate of protein degradation (Schiaffano et al., 2013). Different factors regulate protein synthesis
in the early neonatal life, but it is largely controlled by insulin signaling and amino acid sensing
(Davis and Fiorotto, 2009). Circulating concentrations of insulin, amino acids, and glucose
change in response to diet. Each of these factors stimulate skeletal muscle protein synthesis in
the neonate (Davis and Fiorotto, 2009). Studies performed in vivo and in vitro demonstrate that
insulin stimulates protein synthesis in the skeletal muscle and whole body (Liechty et al., 1992;
Kimball et al., 1998; Wester et al., 2000; Brown and Hay, 2006).
Amino acids, especially leucine, serve as a signal for protein synthesis and are also
precursors for proteins (Kimball and Jefferson, 2006). A postprandial increase in leucine, but not
valine or isoleucine alone, stimulated muscle protein synthesis in neonatal pigs. However, the
response to leucine was less than the synthesis response to a complete amino acid mixture
(Escobar et al., 2005; 2006). The leucine-mediated response in protein synthesis involves the
activation of the mammalian target of rapomycin (mTOR) pathway, and protein synthesis is
partially regulated by mTOR. The mTOR complex 1 (mTORC1) is regulated by growth factors,
energy status, oxygen, and amino acid concentrations and contributes to protein synthesis, lipid
synthesis, and autophagy (Laplante and Sabatini, 2012). Specifically, amino acids, such as
leucine and arginine, act as upstream signals to activate mTORC1 (Blommaart et al., 1995; Hara
et al., 1998). Protein synthesis is directly regulated by mTORC1 since it phosphorylates the
translational regulators eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-
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BP1) and S6 kinase 1 (S6K1), which then promote protein synthesis (Ma and Blenis, 2009). In
addition to regulating muscle protein synthesis, mTORC1 is involved in the synthesis of lipids to
generate membranes, and also positively regulates cellular energy metabolism and ATP
production (Laplante and Sabatini, 2012).

Muscle Metabolism
Muscle and Inter-Organ Metabolism
Skeletal muscle plays an integral role in metabolism and inter-organ crosstalk since it is
involved with glucose and protein metabolism (Meyer et al., 2002). Skeletal muscle comprises
40 to 50% of body mass, making it the most abundant insulin-sensitive tissue (Baron et al., 1988;
DeFronzo et al., 1985; Zurlo et al., 1990). Additionally, skeletal muscle is responsible for 75 to
95% of insulin mediated glucose disposal and is responsible for 20 to 30% of oxygen
consumption (DeFronzo et al., 1985; Baron et al., 1988; Zurlo et al., 1990). Skeletal muscle also
serves as an amino acid reservoir that sustains protein synthesis within the muscle and whole
body (Wolfe, 2006). After a meal, approximately 40% of glucose is taken up by the muscle for
storage as glycogen (Meyer et al., 2002). Glycogen storage facilitates rapid energy production
for fiber contraction even when glucose is not available from the diet (Argiles et al., 2016). As
stores of glycogen become depleted, increasing amounts of energy are generated through the
process of gluconeogenesis (Shrayyef and Gerich, 2010). Muscle is essential for this process
since during times of fasting, protein within muscle can be catabolized to provide energy
substrates and essential amino acids (Frontera and Ochala, 2015). The regulation of glucose is
essential for energy balance within the muscle and whole body. In the cytoplasm of cells,
including skeletal muscle, the process of glycolysis generates energy substrates for ATP
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production from glucose (Argiles et al., 2016). The liver and kidney also store glycogen, and
glucose regulation by these three organs allows the body access to energy substrates. Interactions
between the liver and muscle regulate carbohydrate metabolism and are largely responsible for
achieving energy balance in the fed- and fasted-state (Argiles et al., 2016). Skeletal muscle is
vital to metabolism and overall health since any changes to muscle mass, metabolic rate,
hormone concentrations, or other circulating factors could significantly alter utilization of energy
within the body.

Fiber Type Metabolism
Muscle metabolism is dictated by the characterization and distribution of fibers within
that muscle (Scott et al., 2001). Muscle fiber types are classified based on their speed of
contraction as well as their different need for energy substrates (Scott et al., 2001; Biressi et al.,
2007). Muscle fibers are composed of fibrillary proteins including actin and myosin, and
different muscle fiber types have been classified based on morphological differences of these
filaments. There are three main types of muscle fibers that contribute to skeletal muscle
composition, although variations do occur (Scott et al., 2001). The main classifications are type I
or slow-twitch oxidative, type IIa or fast-twitch oxidative, and type IIb or fast-twitch glycolytic
(Pette et al. 2001). The terms “fast” and “slow” twitch refer to the speed of ATP hydrolysis and
therefore, contraction within the fiber. The slow muscles have an increased myoglobin content
which contributes to their darker red color, whereas the fast muscles have a reduced myoglobin
concentration and appear white or lighter in color (McComas et al., 1996). The greater
myoglobin content allows the slow muscle fibers to have a greater oxidative capacity and
therefore rely on oxidative metabolism (McComas et al., 1996). Oxidative metabolism occurs
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under aerobic conditions and produces 36 ATP per molecule of glucose. Additionally, slow
twitch fibers have a greater density of capillaries and oxidative enzymes, making them more
resistant to fatigue than fast twitch fiber types (Matsakas et al., 2009). Alternatively, the fast
twitch type utilizes anaerobic metabolism, primarily glycolysis, to generate ATP (McComas et
al., 1996). Glycolysis produces only two ATP per glucose molecule. This means that fast twitch
muscles can contract more readily, but fatigue quicker than slow twitch muscles (Matsakas et al.,
2009). The differences in fiber types account for the different movements. Slow-twitch muscles
are necessary for endurance exercise, whereas fast-twitch muscles are necessary for quick and
powerful bursts of movement (Morrison et al., 1970). Fiber types are not permanently fixed
during gestation and throughout postnatal life. Muscle fibers can adapt to altered metabolic
states, which in turn alters fiber type distribution and composition (Daniel et al., 2007; Maltin,
2008; Schiffano et al., 2013). These changes to composition can then influence muscle
metabolism as well as whole body metabolism.

Poor Maternal Nutrition
Both under- and over-feeding during gestation can negatively affect the offspring and
impact both prenatal and postnatal muscle development (Ford et al., 2007). Although there is an
increase in net muscle mass after birth due to hypertrophy, all of the muscle fibers are formed
during gestation (Rowe and Goldspink et al., 1969; Beerman et al., 1978; Wigmore and
Stickland et al., 1983; White et al. 2010). This makes muscle tissue particularly vulnerable to
intrauterine conditions, maternal nutrition, and other factors that can influence muscle
development (Zhu et al., 2006). Skeletal muscle is particularly susceptible to fetal programming
because it is a lower priority tissue. Nutrients are first partitioned to organs such as the brain,
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liver, and heart before muscle (Tchirikov et al., 1998; Yajnik, 2004). Therefore, to maintain vital
organs, any nutritional insult to the mother during gestation can greatly impact muscle formation
(Zhu et al., 2006).

Nutrient Restriction
Reduced feed intake during gestation can impact body and muscle composition as well as
muscle fiber development. For example, dams who faced reduced nutrient intake during
pregnancy produced lambs that were overall fatter and had reduced lean-to-fat ratios (Tygesen et
al., 2007). A study conducted at the University of Connecticut demonstrated that in the
semitendinosus muscle, lipid content was 92.5% greater in offspring from restricted animals
compared with CON at birth. At 3 mo of age, restricted offspring showed a 23.6% decrease in
lipid accumulation in the muscle compared with controls (Reed et al., 2014). This demonstrates
that restricted-feeding alters lipid accumulation in the semitendinosus muscle and therefore
muscle composition.
Nutrient restriction can alter the total number of muscle fibers as well as the distribution
of primary and secondary fibers. A study conducted by Zhu et al., (2004), found that a 50% NRC
nutrient restriction in pregnant ewes from d 28 to 78 of gestation reduced the total number of
secondary muscle fibers and also the ratio of primary to secondary muscle fibers in lambs (Zhu
et al., 2004). These results indicate that fiber development is impaired in response to maternal
restricted-feeding. Another study by Zhu et al. (2006) demonstrated that 8-mo-old lambs born to
nutrient deficient mothers had fewer total muscle fibers than control animals (Zhu et al., 2006).
In addition to impacting the number of fibers within the muscle, nutrient restriction can also alter
the cross-sectional area (CSA) of muscle fibers. Underfeeding ewes during gestation impacted
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offspring muscle CSA. For example, at birth and 3 mo of age, offspring from restricted-fed
mothers weighed the same as offspring from control-fed mothers, but CSA was different (Reed
et al., 2014). CSA of semitendinosus muscle fibers was 57% greater in restricted animals
compared with control (Reed et al., 2014). However, at 3 mo of age, the muscle fiber CSA of the
restricted lambs was reduced by 15% compared with controls (Reed et al., 2014). Maternal
nutrient restriction during gestation similarly impairs cattle skeletal muscle, as demonstrated in a
study conducted by Gonzalez et al. (2013). The fetal infraspinatus (INF) muscle was measured in
calves from heifers fed 60% or 100% NRC from conception to either d 85 or 140 of gestation. At
d 85 of gestation, the restricted offspring had increased muscle fiber CSA compared with the
control group. At d 140, the restricted calves had reduced fiber CSA in the INF muscle
(Gonzalez et al., 2013).
Maternal nutrient-restriction can alter genetic expression of myogenic regulatory factors
of the offspring. Even moderate maternal undernutrition negatively alters fetal muscle
development by impacting the expression of myogenic regulatory factors in the muscle (Zou et
al., 2016). Sows fed a low energy diet from d 1 to 90 of gestation had offspring with reduced
fetal weights and decreased muscle fiber density. The low energy group had reduced mRNA
expression of myogenin, MRF4, and creatine kinase compared with the control group at both d
55 and 90 of gestation in the fetal pig (Zou et al., 2016). Further, restricted maternal diet can alter
genes associated with muscle cell proliferation and signal transduction (Hoffman et al., 2016).
These studies demonstrate that genes involved in myogenesis are altered due to poor maternal
nutrition, which may result in changes to the muscle phenotype in offspring of restricted-fed
dams.
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Nutrient Excess
Maternal over-nutrition during gestation also alters skeletal muscle development.
Myogenesis and adipogenesis occur around the same time during gestation, and excess nutrients
can affect both muscle and fat formation (Tong et al., 2009). Maternal over-feeding during
gestation can result in increased adipogenesis in the muscle and in the carcass as a whole,
changing composition (Tong et al., 2009). Sows who were over-fed from conception to d 50 of
gestation had piglets with increased adiposity in the muscle at birth (Daniel et al., 2007). Huang
et al. (2012) also showed that maternal obesity during gestation produced offspring with
increased collagen and cross-linking in the LD and semitendinosus muscle (Huang et al., 2012).
The excess collagen and crosslinking reduces meat tenderness and makes it less palatable to the
consumer. Further, sows who faced maternal over-nutrition during mid-gestation had offspring
with impaired fiber development and reduced carcass quality (Cerisuelo et al., 2014). Lipid
content in the semitendinosus muscle was 212.4% greater in offspring from over-fed ewes
compared with the controls at birth. At 3 mo of age the over-fed animals had 36.1% greater lipid
accumulation than control animals (Reed et al., 2014). These changes to composition could
negatively impact muscle growth and metabolism.
Maternal over-nutrition can also impact muscle fiber number and fiber distribution. Sows
who were over-fed during gestation had piglets with reduced total, primary, and secondary
fibers, demonstrating that over-feeding during gestation influences prenatal muscle fiber
hyperplasia (Cerisuelo et al., 2014). Fiber diameter can also be reduced by maternal obesity.
Specifically, at birth, lambs from obese ewes had reduced semitendinosus muscle fiber diameter
compared with controls (Tong et al., 2009). Further, increased maternal nutrition during
gestation altered skeletal muscle development in ovine offspring. From birth to 3 mo of age, the
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lambs from over-fed mothers weighed 13% more than control lambs. At birth, CSA of muscle
fibers in the semitendinosus was 47% greater in offspring of over-fed animals compared with
controls. At 3 mo of age, the CSA for the offspring of over-fed dams was reduced by 17% (Reed
et al., 2014). Thus, maternal over-nutrition during gestation impacts myogenesis, resulting in
changes to muscle fiber number, fiber type distribution, and CSA.
Maternal over-nutrition can also influence gene expression within the muscle. In cattle,
maternal over-nutrition increased mRNA expression of adipogenic markers in skeletal muscle
(Duarte et al., 2014). A study in sheep demonstrated that maternal obesity impaired myogenesis
in the semitendinosus by downregulating myogenic markers including MyoD, myogenin and
desmin in offspring from obese mothers compared with controls at birth (Tong et al., 2009).
Additionally, maternal over-nutrition altered genes in offspring muscle related to protein
synthesis, growth, and metabolism (Hoffman et al., 2016). Changes to gene expression can
impact the skeletal muscle and demonstrate that maternal over-nutrition causes negative
programming effects. The negative effects of maternal over-nutrition, including changes to
composition, fiber number, fiber size, and gene expression can impact postnatal muscle growth
and metabolism.

Poor Maternal Nutrition and Stem Cell Function
Poor maternal nutrition during gestation also alters stem cell populations in the offspring,
specifically, satellite cells and mesenchymal stem cells. In mice, Woo et al. (2011) determined
that offspring from restricted-fed mothers had altered muscle composition as well as changes in
satellite cell numbers. Offspring of underfed dams had reduced overall muscle mass, but similar
birth weights to control animals (Woo et al., 2011). Further, satellite cell numbers were reduced
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by 33% in offspring of restricted-fed dams. Satellite cell function was examined later at 6 wk of
age, since these muscle progenitor cells are essential for muscle repair and hypertrophy. During
muscle regeneration, the number of regenerating fibers was reduced by 32% 3 d after injury in
offspring of restricted-fed dams (Woo et al., 2011). Gonzalez et al. (2013) used cattle to
demonstrated that a maternal restricted diet (60% of NRC requirements) reduced the number of
Pax7 positive nuclei in offspring INF by almost 20% at d 85 of gestation, suggesting a loss of
muscle progenitor cells. Additionally, offspring satellite cell function and subsequent
hypertrophy is hindered by maternal restricted feeding (Raja et al., 2016). Satellite cells are
essential for postnatal muscle hypertrophy and muscle repair. Therefore, any insults during
gestation can have lasting impacts of muscle growth. The results of these studies indicate that
satellite cell populations and function are vulnerable to fetal programming.
Mesenchymal stem cells are multipotent stem cells that contribute to the development of
tissues including adipose, bone, and muscle. As part of the bone marrow niche, MSC help
maintain and repair these tissues throughout adult life. MSC are responsive to changes in
hormone and metabolite concentrations, and therefore susceptible to programming. Changes to
maternal diet can cause MSC to favor differentiation into one cell lineage over another (Devlin
and Bouxsein, 2012). Additionally, poor maternal nutrition, both restricted- and over-feeding,
altered proliferation and metabolism of MSC (Pillai et al, 2016). Maternal restricted- and overfeeding reduced MSC proliferation by 51% and 60%, respectively (Pillai et al., 2016).
Mitochondrial basal respiration, ATP production, and maximal respiration were impacted by
over- and under-feeding, indicating changes to the metabolism of the MSC due to maternal
programming (Pillai et al., 2016). Evidence supports that early perturbations to stem cell
populations can have-long lasting impacts on muscle growth and development (Woo et al.,
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2011). Additionally, changes to these stem cell populations may provide insight into some of the
mechanisms by which programming alters muscle metabolism and function.

Effects of Poor Maternal Nutrition on Metabolism
Whole body metabolism
Poor maternal nutrition can cause changes to whole body metabolism, ultimately
affecting muscle. Specifically, poor maternal nutrition alters the intrauterine environment and
concentrations of offspring hormones and growth factors, thereby altering metabolism. For
example, over- and under-feeding ewes during gestation resulted in lambs with decreased serum
concentrations of IGF1 and IGF binding protein 3 at birth (Hoffman et al., 2014). Additionally,
at 3 mo of age, offspring from over-fed ewes had increased leptin concentrations compared with
restricted-fed offspring (Hoffman et al., 2016). In the same study, average insulin concentrations
were increased over time in offspring from over-fed and restricted-fed ewes compared with
controls (Hoffman et al., 2016). Maternal under-nutrition also alters glucose tolerance in the
offspring (Ford et al., 2007). Lambs born to restricted-fed ewes exhibited increased area under
the curve for glucose and insulin at d 63 of age compared with control (Ford et al., 2007).
Further, adult offspring of obese ewes had increased plasma glucose, insulin, and leptin
concentrations after a twelve-week feeding challenge (Long et al., 2010). Early maternal undernutrition also results in altered metabolism. Specifically, maternal under-feeding resulted in
reduced insulin sensitivity and increased insulin secretion in adult offspring (George et al.,
2011). Another study found that in sheep, early gestational under-nutrition caused a reduction in
hepatic expression of gluconeogenic factors as well as reduced insulin sensitivity in the adipose
tissue (Poore et al., 2014). These changes to hormones, growth factors, and metabolism could be
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mechanisms by which metabolism is programmed in response to poor maternal nutrition during
gestation.

Muscle Metabolism and Oxidative Stress
Not only does poor maternal nutrition affect whole body metabolism through changes to
hormones and growth factor concentrations, there are specific programming effects on muscle
metabolism and mitochondrial function. In rats, maternal obesity resulted in offspring with
reduced skeletal muscle glucose transporter 4 (GLUT4) (Simar et al., 2012). There was also
increased monocarboxylate transporter 1 (MCT1) protein (Simar et al., 2012). When these
offspring continued on an obesogenic diet post-weaning, there were continued changes to the
muscle. At 18 weeks of age, the offspring continued to have reduced muscle GLUT4
concentrations, as well as decreased mRNA expression of carnitine palmitoyl transferase-1, and
MyoD and myogenin protein expression (Simar et al., 2012). These findings demonstrate that
maternal obesity could be influencing glucose metabolism and muscle specific gene expression.
Poor maternal nutrition can alter mitochondrial function within skeletal muscle cells.
Mitochondria generate ATP and are essential for cellular energy production and the regulation of
cellular energy metabolism (Hanson, 1989). Both over- and restricted-feeding can alter offspring
mitochondria. A study in mice demonstrated that male offspring from obese mothers had a
decrease in mitochondrial complex II-III as well as impaired insulin signaling in the skeletal
muscle (Shelley et al., 2009). Another in pigs found that in-utero exposure to high energy diets
decreased mitochondrial DNA content in skeletal muscle and downregulated mRNA
concentrations of genes associated with mitochondrial biogenesis and function (Zou et al., 2017).
Additionally, reduced maternal dietary energy intake decreased expression of genes involved in
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mitochondrial biogenesis in the muscle, including peroxisome proliferator-activated receptor
gamma coactivator 1α (PPARGC1A), nuclear respiratory factor 1 (NRF1), mitochondrial
transcription factor A (TFAM), β subunit of mitochondrial H(+)-ATP synthase (ATB5B), sirtuin
1 (Sirt1), and citrate synthase (CS; Zou et al., 2016).
Poor maternal nutrition can affect the fiber type distribution, and therefore skeletal
muscle metabolism in the offspring. For example, over-feeding during gestation altered fibertype proportions in porcine offspring by increasing the number of Type IIA fibers, leading to an
increase in oxidative capacity. However there was no change to muscle fiber CSA or total fiber
number (Markham et al., 2009). Over-feeding during gestation resulted in offspring that had a
13.3% increase in type IIA fibers at birth (Reed et al., 2014). In contrast, restricted feeding
during gestation resulted in offspring that had a 14.6% decrease in type IIA fibers at birth (Reed
at al., 2014). Changes to fiber type distribution can have long-lasting impacts on muscle
metabolism and can additionally result in changes to reactive oxygen species (ROS) and
oxidative stress within the muscle (Jackson, 2005). During muscle contraction, free radicals are
generated, resulting in oxidative damage to the tissue if not properly detoxified (Davies et al.,
1982). Oxidative stress affects the mitochondria and myofibers of muscle, resulting in damage
of the tissue (Davies et al., 1982). Oxidative stress can induce mitochondrial apoptosis (Giorgio
et al., 2005). Due to their redox systems, type I fibers are more resistant to oxidative stress than
type II fibers (Jackson, 2005). Therefore, an increase in type II fibers could indicate a decreased
ability for the offspring to detoxify ROS in the muscle, further impacting growth and
metabolism.
Oxidative stress has many negative effects and can impact tissues such as muscle and
adipose. The amount of ROS production and oxidative stress is dependent on different factors
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such as the muscle fiber type composition and fat content in the muscle (Pinho et al., 2017).
Oxidative stress alters satellite cell differentiation, causing more of these cells to join the
adipocyte rather than the myogenic lineage (Vettor et al., 2009), resulting in increased adipose
within the muscle. Increased oxidative stress is correlated with increased lipid peroxidation,
resulting in mitochondrial damage and metabolic disruption (Davies et al., 1982).
Oxidative stress is associated with muscle dysfunction. Studies indicate that
mitochondrial uncoupling may be a protective mechanism to reduce ROS (Baynes et al., 1991;
MacLellan et al., 2005). This is supported by experiments which demonstrate that mitochondrial
uncoupling protein 3 (UCP3) upregulation reduces ROS production and facilitates fatty acid
oxidation in L6 myocytes (MacLellan et al., 2005). In patients with type 2 diabetes, plasma
hydroperoxides, a marker of oxidative stress, are increased and inversely correlated with
glycemic control (Baynes et al., 1991). Other studies demonstrate that low-grade oxidant stress
reduces insulin-stimulated glucose transport and insulin signaling in insulin sensitive cells such
as L6 myocytes and 3T3-L1 adipocytes (Maddux et al., 2001; Rudich et al., 1997; Rudich et al.,
1998). Continuous evidence supports that oxidative stress is associated with impaired insulin
action and metabolism in muscle.
Poor maternal nutrition induces oxidative stress in offspring. Malti et al. (2014)
demonstrated that mothers who were obese and had nutrient rich diets during gestation had
increased oxidative stress. The offspring of these mothers also had increased amounts of
oxidative stress, implicating a programming effect of maternal diet (Malti et al., 2014). Another
study in humans demonstrated that children of mothers with increased body condition score
(BCS) had increased lipid peroxidation and oxidative stress from ages 8 to 13 (Mohn et al.,
2007). Restricted maternal nutrition can similarly impact oxidative stress and the mechanisms in
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place to modulate it. For example, He et al., (2012) demonstrated that when maternal protein is
restricted, offspring had reduced antioxidant capacity. Even after a period of controlled feeding
and nutrient recovery, these offspring still had impaired ability to detoxify free radicals, leading
to increased oxidative stress (He et al., 2012). Further studies show that redox status is altered by
poor maternal nutrition. Specifically, the expression of the antioxidant magnesium dependent
superoxide dismutase is increased by maternal diet (Tarry-Adkins et al., 2016). Poor maternal
nutrition during gestation may be altering skeletal muscle metabolism by contributing to changes
in fiber type metabolism and inducing oxidative stress.

Conclusion
Optimal livestock production is dependent on proper gestational management and
efficient offspring growth. As a result of poor maternal nutrition, changes to offspring mRNA
and protein expression has the potential to reduce livestock growth rates and lean carcass mass,
as well as impact the health of the offspring (Wu et al., 2004). Specifically, both under- and
over-feeding can impact muscle formation, offspring metabolism, stem cell populations, and
oxidative stress. Muscle is the meat product that consumers buy, and the demand for high quality
protein will only increase as the population expands. Often, offspring from mothers who are
either under- or over-nourished demonstrate divergent muscle phenotypes from control animals.
Alterations to metabolism may be an underlying mechanism that drives these phenotypic
changes. Therefore, it is important to investigate how poor maternal nutrition alters offspring
muscle metabolism. We hypothesized that over- or restricted-feeding during gestation would
alter muscle myoblast metabolism as well as offspring Longissimus dorsi muscle (LD)
metabolome.
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MATERIALS AND METHODS
Animals
All animal procedures were reviewed and approved by the University of Connecticut
Institutional Animal Care and Use Committee (A13-059). Animal procedures were previously
reported in Pillai et al. (2017). Multiparous Western White-faced ewes (n = 47), aged 3 years or
older were estrus synchronized using a controlled intravaginal drug release device (CIDR; EasiBreed CIDR Sheep Insert, Zoetis, Parsippany, NJ). The CIDR was inserted intravaginally and
removed from each ewe after 12 days. Following this, the ewes were given an intramuscular
injection of PGF2α [Lutalyse, 5 mg/mL; Zoetis, Inc.; (Knights et al., 2001)]. The ewes were
housed in a group and bred to 1 of 4 related Dorset rams. Day 0 of pregnancy was determined
when ewes received a rump mark and showed no further evidence of remarking. Twenty days
later, ewes were moved to 3 x 1 m individual pens that allowed visual but not physical contact
with other ewes and individually fed. Ewes were transitioned to a complete pelleted feed based
on National Research Council (NRC) requirements for ewes gestating with twins, over a 7-day
period starting at d 20. Using transabdominal ultrasound, 47 ewes were confirmed pregnant on d
28.5 ± 0.4 (Jones et al., 2016). At d 30, ewes were randomly assigned to a 3 x 4 factorial
arrangement of treatment structure with main effects of diet (3) and time point of gestation (4; n
= 5 to 7 ewes per treatment). Pregnant ewes were fed either a control-fed (CON; 100% NRC; n =
27), restricted-fed (RES; 60% NRC; n = 28), or over-fed diet (OVER; 140% NRC; n = 27)
starting at d 30.2 ± 0.2 of gestation based on the NRC requirement for TDN (National Research
Council, 1985). Based on ewe body weight, treatment diets (Central Connecticut Farmer’s
COOP, Manchester, CT) of 60, 100, or 140% NRC were achieved by offering differing amounts
of complete pelleted feed (Pillai et al., 2017). For each grain delivery (n = 3), analysis of
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nutrients was completed by Dairy One (Ithaca, NY). Blocks containing sodium chloride and
fresh water were freely available to the ewes. At the beginning of treatment and weekly
thereafter, ewes were weighed and body condition score (BCS) was independently evaluated on
a scale of 1-5 by 2 trained observers. Offspring born to control-, restricted-, or over-fed ewes are
denoted as CON, RES and OVER, respectively.

Sample Collection
At d 90 and 135 of gestation, ewes (n = 5 to 7 per treatment combination) were weighed
and euthanized. An intravenous injection of Beuthanasia-D Special (Merck Animal Health;
Summit, NJ) containing 390 mg/mL sodium pentobarbitol and 50 mg/mL phenytoin based on
body weight was given to each ewe. Following the injection, each ewe was exsanguinated as
previously detailed (Reed et al., 2014). The fetuses were removed following a hysterectomy for
necropsy and tissue analysis to evaluate the effects of restricted- and over-feeding on offspring
development during gestation. A subset of ewes were allowed to undergo parturition (birth; n = 5
to 7 per dietary treatment). Lambs were allowed to nurse colostrum for up to 24 hours after birth.
Lambs were offered colostrum replacer (4 ewes total: 2 twin control litters and 2 twin restricted
litters; DuMor Blue Ribbon Multi-Species Colostrum Supplement; Distributed by Tractor Supply
Company, Brentwood, TN) if the ewe did not produce sufficient colostrum. Within 24 hours of
birth, lambs were weighed and euthanized with an i.v. overdose of Beuthanasia-D Special (390
ng/mL Sodium Pentobarbital and 50 mg/mL Phenytoin based on BW) and exsanguinated.
Due to reasons unrelated to the study, four ewes did not complete the experiment. Five
offspring were not viable and therefore not included in the experiment (2 mummified and 3
stillborn). For the purposes of these experiments, a total of 72 offspring (n = 8 per treatment per
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time point) from 47 ewes at d 90 and 135, and within 24 hours of birth were included in the final
analysis.
Muscle samples from each offspring at d 90, 135, and birth were collected from the LD
immediately after euthanasia and samples were immediately snap frozen in liquid nitrogen.
Samples were stored at −80°C until further use. Whole blood was obtained from live lambs at the
birth time point via jugular venipuncture and processed for serum within 24 hours of parturition.

Figure 1. Experimental design, adapted from Pillai et al. (2017). To evaluate the effects of
restricted- or over-feeding on offspring development during gestation, pregnant ewes (n = 82)
were housed in individual pens on d 20 of gestation (Individual housing) and randomly assigned
into a 3 × 4 factorial arrangement of treatments which began at d 30 of gestation (Diet). The
treatment structure included 3 dietary levels (CON: 100% TDN; RES: 60% TDN; OVER: 140%
TDN) and 4 time points during gestation (n = 5 to 7 ewes per treatment combination). At d 90 or
135 of gestation, ewes were euthanized and the fetus(es) were removed for necropsy and tissue
analysis. A third group of ewes underwent parturition (birth), after which lambs were necropsied
within 24 h of parturition.
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C2C12 Cell Culture
Proliferation
C2C12 cells (ATCC CRL-1772, Manassas, VA) were cultured in growth media
containing Dulbecco’s modified Eagle medium (DMEM) with 4 g/L D-glucose (Gibco
Laboratories, Gaithersburg, MD) and 10% fetal bovine serum (FBS), 1% penicillin/
streptomycin, 0.3% fungizone, and 0.2% gentamycin. Cells were passed once and plated on 24well plates at a density of 3,000 cells per well. Cells were allowed to attach and proliferate in
growth media for 24 hours. After 24 hours, the media was changed so that the growth media
contained 10% offspring serum instead of FBS. Serum collected from CON (n = 8), RES (n = 8),
and OVER (n = 8) lambs at birth was added to media in duplicate wells. Each plate contained
two wells cultured in growth media with FBS to serve as a plate control. Following the
manufacturer’s instructions, after 48 hours, the cells were pulsed with 5-bromo-2'-deoxyuridine
(BrdU) for 30 minutes (Click-iT EdU Alexa Fluor 488 Imaging Kit, Invitrogen, Carlsbad, CA),
fixed with 4% paraformaldehyde, and immunostained to measure the percentage of cells in Sphase. Cells were incubated with Hoescht 33342 for 1 hour to visualize nuclei. The cells were
imaged using a Zeiss Observer, and 5 random images per well were taken. The percentage of
proliferating cells was determined by the number of BrdU(+) cells divided by the total number of
nuclei and multiplied by 100. Each experiment was replicated once.

Differentiation
C2C12 cells were cultured in growth media containing DMEM with 4 g/L D-glucose,
10% FBS, 1 % penicillin/ streptomycin, 0.3% fungizone, and 0.2% gentamycin. Cells were
passed once and plated onto 24-well plates at a density of 25,000 cells per well. Cells were
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allowed to attach and proliferate in growth media for 72 hours to reach 100% confluency. After
72 hours, the media was changed to differentiation media containing 2% offspring serum, 1%
penicillin/ streptomycin, 0.3% fungizone, and 0.2% gentamycin. Serum from CON (n = 8), RES
(n = 8), and OVER (n = 8) lambs was added to media in duplicate wells. C2C12 cells were
cultured in their individual media and allowed to differentiate in treatment media for 5 days.
Each plate contained two wells differentiated in differentiation media containing horse serum to
serve as a plate control. To determine the effects of offspring serum on differentiation, myotubes
were fixed with 4% paraformaldehyde and immunostained for myosin heavy chain (MyHC;
Appendix 1). Hoescht 33342 was used to visualize nuclei. The cells were imaged using a Zeiss
Observer, and 5 random images per well were taken. Fusion index was calculated as the number
of nuclei within multinucleated MyHC-positive myotubes divided by the number of total number
of nuclei and multiplied by 100. Fiber diameter was calculated by determining the average width
(diameter measured in 3 places) of MyHC-positive myofibers in each image. Each experiment
was replicated once.

Mitochondrial and Glycolytic Stress Assays
Mitochondrial and glycolytic stress were evaluated using the Seahorse XFe24
Extracellular Flux Analyzer (Seahorse Bioscience; North Billercia, MA) following
manufacturer’s instructions and protocol. In brief, C2C12 cells were plated onto XFe24 culture
plates at a density of 15,000 cells per well and cultured in 10% offspring serum in growth media
[CON (n = 6), RES (n = 6), or OVER (n = 6)] for 24 hours. Twelve hours before the assay, the
XFe24 sensor cartridges were hydrated with Seahorse Bioscience XFe24 Calibrant (pH 7.4) and
stored at 37°C.
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For the Cell Mito Stress Test Assay (Appendix II), 1 mM pyruvate (Sigma-Aldrich, St
Louis, MO), 2 mM glutamine (Sigma-Aldrich), and 10 mM glucose (Sigma-Aldrich) were added
to the assay medium, warmed to 37°C, pH was adjusted to 7.4 with 0.1 N NaOH, and the media
was sterile filtered. Oligomycin, carbonyl cyanide-4 (trifluoromethoxy) phenylhydrazone
(FCCP), and rotenone/antimycinA were re-suspended with 630 μL, 720 μL, and 540 μL of
prepared assay medium, respectively. The injection ports were loaded using the constant volume
method described in the manufacturer’s protocol. The maintenance medium was removed with a
pipette, and each well was rinsed twice with assay media. Assay media (525 μL) was added to
each well, and the cell culture plate was incubated at 37°C without CO2 for 60 minutes. The plate
was then loaded into the Seahorse XFe24 Extracellular Flux Analyzer and the standard operating
procedure for Cell Mito Stress Test Assay for the machine was followed according to
manufacturer’s protocol to measure oxygen consumption rate (OCR).
For the Glycolysis Stress Test Assay (Appendix III), 2 mM glutamine was added to
Seahorse XF Assay Media (Seahorse Bioscience). The media was warmed to 37°C, pH was
adjusted to 7.4 with 0.1 N NaOH, and the media was filter sterilized. The injection ports were
loaded using the constant volume method described in the manufacturer’s protocol. The
maintenance medium was removed with a pipette, and each well was rinsed twice with assay
medium. Assay media (525 μL) was added to each well, and the cell culture plate was incubated
at 37°C without CO2 for 60 minutes. The plate was then loaded into the Seahorse XFe24
Extracellular Flux Analyzer. Standard operating procedure for Glycolysis Stress Test Assay for
the machine was followed according to manufacturer’s protocol to measure extracellular
acidification rate (ECAR).
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The DNA content in individual wells on the XFe24 cell culture plates was quantified to
account for variations in cell density using Macharey-Nagel NucleoSpin Tissue kits (MachareyNagel Inc, Bethlehem, PA, USA), according to manufacturer’s protocol. The OCR and ECAR
measurements were adjusted for total DNA content in each well.

Metabolome Analysis
Sample Preparation
Longissimus dorsi samples (200 ng; n = 8 per treatment per time point) were shipped on
dry ice to Metabolon, Inc. (Morrisville, NC) for metabolome analysis. Samples were prepared
using the automated MicroLab STAR® system (Hamilton Company). Several recovery
standards were added prior to the first step in the extraction process for quality control (QC)
purposes. To remove protein, dissociate small molecules bound to protein or trapped in the
precipitated protein matrix, and to recover chemically diverse metabolites, proteins were
precipitated with methanol under vigorous shaking for 2 min (Glen Mills GenoGrinder 2000,
SPEX Sample Prep, Metuchen, NJ) followed by centrifugation. The resulting extract was divided
into five fractions: two for analysis by two separate reverse phase (RP)/ Ultra-performance liquid
chromatography-tandem mass spectrometry (UPLC-MS/MS) methods with positive ion mode
electrospray ionization (ESI), one for analysis by RP/UPLC-MS/MS with negative ion mode
ESI, one for analysis by Hydrophilic Interaction Chromatography (HILIC)/UPLC-MS/MS with
negative ion mode ESI, and one sample was reserved for backup. Samples were placed briefly on
a TurboVap® (Zymark, Hopkinton, MA) to remove the organic solvent. The sample extracts
were stored overnight under nitrogen before preparation for analysis.

Quality Assurance/ Quality Control
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Several types of controls were analyzed in concert with the experimental samples: a
pooled matrix sample generated by taking a small volume of each experimental sample served as
a technical replicate throughout the data set; extracted water samples served as process blanks;
and a cocktail of QC standards that were carefully chosen not to interfere with the measurement
of endogenous compounds were spiked into every analyzed sample allowed instrument
performance monitoring and aided chromatographic alignment. Instrument variability was
determined by calculating the median relative standard deviation (RSD) for the standards that
were added to each sample prior to injection into the mass spectrometers. Overall process
variability was determined by calculating the median RSD for all endogenous metabolites (i.e.,
non-instrument standards) present in 100% of the pooled matrix samples. Experimental samples
were randomized across the platform run with QC samples spaced evenly among the injections.

Ultrahigh Performance Liquid Chromatography-Tandem Mass Spectroscopy (UPLC-MS/MS)
All methods utilized a Waters ACQUITY ultra-performance liquid chromatography
(UPLC) and a Thermo Scientific Q-Exactive high resolution/accurate mass spectrometer
interfaced with a heated electrospray ionization (HESI-II) source and Orbitrap mass analyzer
operated at 35,000 mass resolution. The sample extract was dried then reconstituted in solvents
compatible to each of the four methods. Each reconstitution solvent contained a series of
standards at fixed concentrations to ensure injection and chromatographic consistency. One
aliquot was analyzed using acidic positive ion conditions, chromatographically optimized for
more hydrophilic compounds. In this method, the extract was gradient eluted from a C18 column
(Waters UPLC BEH C18-2.1x100 mm, 1.7 µm) using water and methanol, containing 0.05%
perfluoropentanoic acid (PFPA) and 0.1% formic acid (FA). Another aliquot was also analyzed
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using acidic positive ion conditions; however it was chromatographically optimized for more
hydrophobic compounds. In this method, the extract was gradient eluted from the same afore
mentioned C18 column using methanol, acetonitrile, water, 0.05% PFPA and 0.01% FA and was
operated at an overall higher organic content. Another aliquot was analyzed using basic negative
ion optimized conditions using a separate dedicated C18 column. The basic extracts were
gradient eluted from the column using methanol and water, however with 6.5mM Ammonium
Bicarbonate at pH 8. The fourth aliquot was analyzed via negative ionization following elution
from a HILIC column (Waters UPLC BEH Amide 2.1x150 mm, 1.7 µm) using a gradient
consisting of water and acetonitrile with 10mM Ammonium Formate, pH 10.8. The Mass Spec
(MS) analysis alternated between MS and data-dependent sequential mass spectrometry (MSn)
scans using dynamic exclusion. The scan range varied slighted between methods but covered 701000 m/z.

Data Extraction and Compound Identification
Raw data were extracted, peak-identified and QC processed using Metabolon’s hardware
and software. Compounds were identified by comparison to library entries of purified standards
or recurrent unknown entities. Metabolon maintains a library based on authenticated standards
that contains the retention time/index (RI), mass to charge ratio (m/z), and chromatographic data
(including MS/MS spectral data) on all molecules present in the library. Furthermore,
biochemical identifications are based on three criteria: retention index within a narrow RI
window of the proposed identification, accurate mass match to the library +/- 10 ppm, and the
MS/MS forward and reverse scores between the experimental data and authentic standards. The
MS/MS scores are based on a comparison of the ions present in the experimental spectrum to the
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ions present in the library spectrum. While there may be similarities between these molecules
based on one of these factors, the use of all three data points can be utilized to distinguish and
differentiate compounds. More than 3,300 commercially available purified standard compounds
have been acquired and registered into the laboratory information management system (LIMS)
for analysis on all Metabolon platforms for determination of their analytical characteristics.

Statistical Analysis
Cell Culture Data
All data were analyzed using PROC MIXED (SAS Inst. Inc., Cary, NC; version 9.4).
Main effects of treatment, gender, and their interaction were analyzed and differences between
means were determined using the pdiff statement in LSMEANS. Data are reported as mean ±
SE. Main effects are discussed in the absence of a treatment by gender interaction. Significance
is tested at P ≤ 0.05.

Metabolome Data
Data were analyzed using one-way ANOVA, two-way ANOVA, two-way repeated
measures ANOVA, and correlation analysis to obtain P and q values. Statistical significance is
declared for P-values less than 0.05. A principal components analysis was performed to find
hierarchical clusterings of the data. Each principal component is a linear combination of every
metabolite and the principal components are uncorrelated. The number of principal components
is equal to the number of observations.
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RESULTS

Offspring serum alters C2C12 myoblast metabolism but not proliferation or differentiation
Serum collected from offspring born to over- and restricted-fed ewes had no effect on
BrDU incorporation (Figure 1) compared with CON (P ≥ 0.39; CON = 24.89 ± 3.03%, RES =
24.06 ± 3.03%, OVER = 27.74 ± 3.03%). Additionally, serum collected from OVER and RES
offspring had no effect on myofiber fusion index (Figure 2A; P ≥ 0.15; CON = 15.70 ± 2.87%,
RES = 9.55 ± 3.23%, OVER = 10.97 ± 3.03%) or myofiber diameter (Figure 2B; P ≥ 0.70; CON
= 15.38 ± 1.33 μm, RES = 14.88 ± 1.46 μm, OVER = 15.25 ± 1.38 μm) compared with CON.
Serum from RES offspring increased proton leak (P = 0.01; Figure 3, CON = 14.98 ±
1.81, RES = 22.33 ± 1.81 pmol O2 ·min-1 ·µg-1 DNA), but serum from OVER offspring had no
effect on proton leak (P = 0.57.; OVER = 16.45 ± 1.81 pmol O2 ·min-1 ·µg-1 DNA ) compared
with CON. Serum from offspring of restricted- and over-fed ewes had no effect on basal
respiration (P ≥ 0.32; CON = 34.32 ± 3.88, RES = 44.87 ± 3.88, OVER = 35.38 ± 3.88, pmol O2
·min-1 ·µg-1 DNA), ATP production (P ≥ 0.69; CON = 19.33 ± 3.21, RES = 22.54 ± 3.21, OVER
= 18.94 ± 3.21 pmol O2 ·min-1 ·µg-1 DNA), maximal respiration (P ≥ 0.17; CON = 177.15 ±
49.83, RES = 303.21 ± 49.83, OVER = 182.58 ± 49.83 pmol O2 ·min-1 ·µg-1 DNA), spare
respiratory capacity (P ≥ 0.19; CON = 142.83 ± 47.79, RES = 258.34 ± 47.79, OVER = 147.19 ±
47.79 pmol O2 ·min-1 ·µg-1 DNA), or non-mitochondrial respiration (P ≥ 0.25; CON = 11.75 ±
5.42, RES = 25.22 ± 5.42, OVER = 16.77 ± 5.42 pmol O2 ·min-1 ·µg-1 DNA) compared with
CON. There was no effect of gender (P ≥ 0.22) for any of the variables analyzed for
mitochondrial function.
Serum from offspring of restricted- and over-fed ewes had no effect on C2C12 glycolytic
function (Figure 4). The variables of glycolysis (P ≥ 0.27; CON = 48.03 ± 4.08, RES = 45.21 ±
32

4.08, OVER = 41.39 ± 4.08 mPh ·min-1 ·µg-1 DNA), glycolytic capacity (P ≥ 0.51; CON = 51.41
± 4.75, RES = 52.35 ± 4.75, OVER = 47.85 ± 4.75 mPh ·min-1 ·µg-1 DNA), glycolytic reserve (P
≥ 0.19; CON = 3.38 ± 1.91, RES = 7.14 ± 1.91, OVER = 6.46 ± 1.91 mPh ·min-1 ·µg-1 DNA),
and non-glycolytic acidification (P ≥ 0.40; CON = 15.63 ± 1.93, RES = 16.69 ± 1.93, OVER =
14.33 ± 1.93 mPh ·min-1 ·µg-1 DNA) were not affected by treatment. There was no effect of
gender (P ≥ 0.28) for any of the variables analyzed for glycolytic function.

Muscle Metabolome Analysis
A total of 612 metabolites were detected in LM samples. Maternal diet altered metabolite
concentrations at d 90, d 135, and birth (Table 1). At d 90, 86 metabolites were altered in RES
offspring (P ≤ 0.05), 19 increased and 67 decreased, compared with CON. At d 135, 72
metabolites were altered in RES offspring (P ≤ 0.05), 22 increased and 50 decreased, compared
with CON. At birth, 64 metabolites were altered RES offspring (P ≤ 0.05), 14 increased and 50
decreased, compared with CON. The OVER offspring had a total of 78 metabolites altered at d
90 compared with CON (P ≤ 0.05), with 49 metabolites increased and 29 decreased. At d 135
OVER offspring had 27 metabolites altered (P ≤ 0.05), 18 increased and 9 decreased, compared
with CON. At birth, OVER offspring had 102 metabolites altered (P ≤ 0.05), 15 increased and 87
decreased, compared with CON. At d 90 RES offspring had 104 metabolites altered (P ≤ 0.05),
20 increased and 84 decreased, compared with OVER. At d 135, RES offspring had 118
metabolites altered (P ≤ 0.05), 38 increased and 80 decreased, compared with OVER. At birth,
RES offspring had 117 metabolites altered (P ≤ 0.05), 85 increased and 32 decreased, compared
with OVER.
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Day of gestation altered metabolite concentrations within each treatment group (Table 2).
In the CON treatment group, 362 metabolites were altered at d 90 compared with d 135, with
200 increased and 162 decreased. A total of 436 metabolites were altered at d 90 compared with
birth, with 191 increased and 245 decreased. Compared with birth, 374 metabolites were altered
at d 135, with 127 increased and 247 decreased. In the RES treatment group, 376 metabolites
were altered at d 90 compared with d 135, with 211 increased and 165 decreased. Compared with
birth, 441 metabolites were altered at d 90, with 189 increased and 252 decreased. Additionally,
374 metabolites were altered at d 135 compared with birth, with 129 increased and 245
decreased. In the OVER treatment group, 374 metabolites were altered at d 90 compared with d
135, with 219 increased and 155 decreased. A total of 441 metabolites were altered at d 90
compared with birth, with 230 increased and 211 decreased. There were 365 metabolites altered
at d 135 compared with birth, with 160 increased and 205 decreased. Principle component
analysis of LM samples (Figure 5) demonstrated close clustering in response to day of gestation,
indicating that time is the primary driver of variance between samples.
Both maternal over- and restricted-feeding altered metabolites in each of the 8 major
metabolic pathways (Table 3). For amino acid metabolism, and 63 of 161 identified metabolites
were altered in OVER compared with CON (P < 0.05). For peptide metabolism, 6 of 17
identified metabolites were altered in OVER compared with CON (P < 0.05). For carbohydrate
metabolism, 12 of 39 identified metabolites were altered in OVER compared with CON (P <
0.05). For energy metabolism, 1 of 11 identified metabolites were altered in OVER compared
with CON (P < 0.05). For lipid metabolism 70 of 268 identified metabolites were altered in
OVER compared with CON (P < 0.05). For nucleotide metabolism 10 of 56 identified
metabolites were altered in OVER compared with CON (P < 0.05). For cofactors and vitamins,
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15 of 31 identified metabolites were altered in OVER compared with CON (P < 0.05). For
xenobiotics, 10 of 29 identified metabolites were altered in OVER compared with CON (P <
0.05). Maternal restricted-feeding additionally altered metabolites in each of the 8 major
metabolic pathways. For amino acid metabolism, 53 of 161 metabolites were altered in RES
compared with CON (P < 0.05). For peptide metabolism, 4 of 17 metabolites were altered in
RES compared with CON (P < 0.05). For carbohydrate metabolism, 8 of 39 metabolites were
altered in RES compared with CON (P < 0.05). For energy metabolism, 1 of 11 metabolites were
altered in RES compared with CON (P < 0.05). For lipid metabolism 89 of 268 metabolites were
altered in RES compared with CON (P < 0.05). For Nucleotide metabolism 16 of 56 metabolites
were altered in RES compared with CON (P < 0.05). For cofactors and vitamins, 12 of 31
metabolites were altered in RES compared with CON (P < 0.05). For xenobiotics, 13 of 29
metabolites were altered in RES compared with CON (P < 0.05).
A total of 43 pathways were altered by the interaction of treatment and time, including
fatty acid metabolism, lysophospholipid metabolism, and sphingolipid metabolism (Table 4).
Maternal diet altered 51 pathways, including phosphatidylethanolamine metabolism, histidine
metabolism, and phosphatidylcholine metabolism (Table 5). Day of gestation altered 85
pathways including ceramide metabolism, diacylglycerol metabolism, acyl carnitine metabolism,
and branched chain amino acid metabolism (Table 6). In RES offspring, 33 pathways were
altered at d 90 (Table 7, 39 pathways were altered at d 135 (Table 8), and 32 pathways were
altered at birth (Table 9) compared with CON. In OVER offspring, 40 pathways were altered at d
90 (Table 10), 19 pathways were altered at d 135 (Table 11), and 43 pathways were altered at
birth (Table 12) compared with CON.
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Maternal over-feeding alters carbohydrate metabolism in the offspring
Maternal over-feeding altered N6-carboxymethyllysine, an advanced glycation end
product, in the offspring (Figure 6). No changes were observed between OVER and CON at d 90
or 135, but at birth, N6-carboxymethyllysine was increased 1.61-fold compared with CON (P =
0.02).

Maternal over-feeding alters amino acid metabolism in the offspring
Increased maternal nutrient consumption altered alanine and aspartate metabolism in the
offspring (Figure 7). At d 90, alanine was increased (fold change = 1.21; P = 0.03) in OVER
compared with CON. However, N-acetylasparagine (fold change = 0.56; P = 0.001) and
hydroxyasparagine (fold change = 0.75; P = 0.04) were decreased in OVER compared with
CON. At d 135 N-acetylaspartate (NAA; fold change = 0.63; P = 0.03) was decreased. At birth
N-methylalanine (fold change = 1.32; P = 0.04) was increased, and alanine (fold change = 0.80;
P = 0.01), N-acetylalanine (fold change = 0.71; P = 0.001), aspartate (fold change = 0.60; P =
0.002), asparagine (fold change = 0.66; P = 0.02), and hydroxyasparagine (fold change = 0.72; P
= 0.03) were decreased in OVER compared with CON.
The OVER offspring also exhibited changes to glutathione metabolism (Figure 8). At d
90, reduced glutathione (GSH; fold change = 2.62; P = 0.005), was increased in OVER
compared with CON, while cystine-glutathione disulfide (fold change = 0.36; P = 0.04) and 2aminobutyrate (fold change = 0.54; P = 0.03) were increased. At d 135, opthalmate (fold change
= 0.38; P = 0.0002) was decreased, and at birth S-methylglutathione (fold change = 0.61; P =
0.04) was decreased in OVER compared with CON.
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Increased maternal nutrient consumption impacted histidine metabolism (Figure 9). At d
90, maternal over-feeding increased carnosine (fold change = 1.18; P = 0.03) and decreased 1methylhistidine (fold change = 0.57; P = 0.007), 3-methylhistidine (fold change = 0.60; P =
0.007), and N-acetyl-1-methylhistidine (fold change = 0.25; P = 0.00001) compared with CON.
At d 135, OVER offspring exhibited increased imidazole propionate (fold change = 2.73; P =
0.03) and formiminoglutamate (fold change = 2.27; P = 0.05) compared with CON. At birth, 1methylhistamine was decreased 0.50-fold (P = 0.03) in OVER compared with CON.
Maternal over-feeding resulted in changes to leucine, isoleucine and valine metabolism in
the offspring muscle (Figure 10). 4-methyl-2-oxopentanoate (fold change = 0.56; P = 0.04) was
decreased, whereas beta-hydroxyisovalerate (fold change = 2.09; P = 0.002), betahydroxyisovaleroylcarnitine (fold change = 1.56; P = 0.01), 3-methylglutaconate (fold change =
1.89; P = 0.01), and 3-hydroxyisobutyrate (fold change = 1.58; P = 0.02) were increased at d 90
in OVER compared with CON. At d 135, beta-hydroxyisovalerate (fold change = 1.58; P =
0.02), 3-methylglutaconate (fold change = 1.76; P = 0.01), and 3-hydroxyisobutyrate (fold
change = 1.59; P = 0.01) continued to be increased.
The OVER offspring exhibited divergent tryptophan metabolism (Figure 11). Nformylanthranilic acid (fold change = 2.16; P = 0.01) and indolelactate (fold change = 1.68; P =
0.007) were increased while 3-indoxyl sulfate (fold change = 0.59; P = 0.04) was decreased at d
90 in OVER compared with CON. Indolelactate (fold change = 1.58; P = 0.01) was increased at
d 135 in OVER offspring. A birth, indoleacetate (fold change = 0.49; P = 0.05) and 3-indoxyl
sulfate (fold change = 0.36; P = 0.0003) were decreased in offspring from over-fed ewes when
compared with CON.
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Finally, maternal over-feeding caused changes to tyrosine metabolism in the offspring
(Figure 12). Tyrosine (fold change = 1.41; P = 0.02), 3-(4-hydroxyphenyl)lactate (fold change =
1.90; P = 0.001), and phenol sulfate (fold change = 1.44; P = 0.04) were increased at d 90 in
OVER compared with CON, while 3-methoxytyrosine (fold change = 0.49; P = 0.01) was
decreased. 3-methoxytyrosine (fold change = 0.60; P = 0.03) continued to be decreased in OVER
at d 135. There were no changes observed at birth.

Maternal over-feeding alters offspring lipid metabolism
Over-feeding altered fatty acid and branched chain amino acid metabolism at birth by
decreasing propionylcarnitine (C3) 0.35-fold (P = 0.01; Figure 13). Maternal over-feeding
caused no changes to this pathway at d 90 and 135. Offspring of over-fed ewes exhibited
changes to fatty acid and acyl carnitine metabolism (Figure 14). At d 90 and 135, no metabolites
involved in fatty acid and acyl carnitine metabolism were altered compared with CON. However,
at birth, 3-hydroxybutyrylcarnitine was increased 1.76-fold (P = 0.04). At the same time-point,
OVER exhibited decreased 5-dodecenoylcarnitine (C12:1; fold change = 0.55; P = 0.003),
linolenoylcarnitine (C18:3; fold change = 0.78; P = 0.006), myristoleoylcarnitine (C14:1; fold
change = 0.60; P = 0.02), adrenoylcarnitine (C22:4; fold change = 0.45; P = 0.001),
behenoylcarnitine (C22; fold change = 0.46; P = 0.01), docosatrienoylcarnitine (C22:3; fold
change = 0.54; P = 0.01), docosapentaenoylcarnitine (C22:5n3; fold change = 0.44; P = 0.0009),
docosahexaenoylcarnitine (C22:6; fold change = 0.61; P = 0.005), margaroylcarnitine (C17; fold
change = 0.67; P = 0.03), and nervonoylcarnitine (C24:1) (fold change = 0.34; P = 0.003)
compared with CON.
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Lysophospholipid metabolism was altered by maternal over-feeding, especially at birth
(Figure 15). At d 90, 1-palmitoleoyl-GPC (16:1; fold change = 1.22; P = 0.03) and 1-oleoyl-GPG
(18:1; fold change = 1.39; P = 0.02) were increased in OVER compared with CON. No changes
were identified at d 135. However, at birth, 13 lysophospholipid metabolites were decreased
compared with CON [1-palmitoyl-GPC (16:0; fold change = 0.82; P = 0.03), 1-palmitoleoylGPC (16:1; fold change = 0.82; P = 0.04), 1-stearoyl-GPC (18:0; fold change = 0.75; P = 0.005),
1-oleoyl-GPC (18:1; fold change = 0.76; P = 0.0008), 1-linoleoyl-GPC (18:2; fold change =
0.54; P = 0.005), 1-palmitoyl-GPE (16:0; fold change = 0.63; P = 0.0001), 1-stearoyl-GPE (18:0;
fold change = 0.71; P = 0.0003), 1-oleoyl-GPE (18:1; fold change = 0.75; P = 0.0006), 1linoleoyl-GPE (18:2; fold change 0.51= ; P = 0.0008), 1-arachidonoyl-GPE (20:4n6; fold change
= 0.65; P = 0.02), 1-palmitoyl-GPI (16:0; fold change = 0.68; P = 0.03), 1-stearoyl-GPI (18:0;
fold change = 0.63; P = 0.02), and 1-oleoyl-GPI (18:1; fold change = 0.61; P = 0.02)].
Maternal over-feeding also caused extensive changes to metabolites involved
phosphatidylethanolamine metabolism, especially at the birth time-point (Figure 16). No changes
were identified at d 90. At d 135, 1,2-dipalmitoyl-GPE (16:0/16:0; fold change = 1.44; P = 0.01)
was increased at in OVER compared with CON. At birth, 10 of 11 metabolites identified in this
pathway were decreased in OVER compared with CON [1-palmitoyl-2-oleoyl-GPE (16:0/18:1;
fold change = 0.68; P = 0.002), 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4; fold change = 0.61;
P = 0.002), 1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6; fold change = 0.54; P = 0.002), 1palmitoleoyl-2-oleoyl-GPE (16:1/18:1; fold change = 0.68; P = 0.006), 1-stearoyl-2-oleoyl-GPE
(18:0/18:1; fold change = 0.67; P = 0.0), 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4; fold change
= 0.70; P = 0.0), 1,2-dioleoyl-GPE (18:1/18:1; fold change = 0.67; P = 0.005), 1-oleoyl-2linoleoyl-GPE (18:1/18:2; fold change = 0.47; P = 0.01), 1-oleoyl-2-arachidonoyl-GPE
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(18:1/20:4; fold change = 0.73; P = 0.006), and 1-oleoyl-2-docosahexaenoyl-GPE (18:1/22:6;
fold change = 0.73; P = 0.03)].

Maternal restricted-feeding alters offspring amino acid metabolism
Lambs born to restricted-fed ewes exhibited changes in muscle glutamate metabolism
(Figure 17). Glutamate, gamma-methyl ester (fold change = 1.53; P = 0.006) and gammaaminobutyrate (GABA; fold change = 1.27; P = 0.03) were increased at d 90 in RES compared
with CON. Glutamate (fold change = 0.85; P = 0.03) was decreased at d 135 and remained
decreased at birth (fold change = 0.78; P = 0.0006) along with N-methyl-GABA (fold change =
0.64; P = 0.006) in RES compared with CON.
Glutathione metabolism was also impacted by restricted-maternal diet (Figure 18). At d
90, reduced glutathione (GSH) was increased 3.07-fold (P = 0.008), and 2-aminobutyrate was
decreased 0.54-fold (P = 0.005) in RES compared with CON. At d 135, oxidized glutathione
(GSSG) was decreased 0.21-fold (P = 0.02) and 2-aminobutyrate (P = 0.001) was increased
1.93-fold in RES compared with CON. There were no changes to glutathione metabolism at birth
in offspring from restricted-fed mothers.
Restricted-feeding altered offspring muscle histidine metabolism (Figure 19). No changes
were observed at d 90. However, at d 135, 1-methylhistidine (fold change = 2.69; P = 0.00001),
3-methylhistidine (fold change = 3.38; P = 0.00001), N-acetyl-1-methylhistidine (fold change =
3.74; P = 0.0), formiminoglutamate (fold change = 2.95; P = 0.00001), and anserine (fold change
= 1.41; P = 0.003) were increased while imidazole propionate (fold change = 0.20; P = 0.008)
and carnosine (fold change = 0.85; P = 0.03) were decreased in RES compared with CON.
Additionally, at birth, imidazole lactate (fold change = 0.64; P = 0.05), carnosine (fold change =
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0.80; P = 0.003), anserine (fold change = 0.80; P = 0.03), and 1-methyl-4-imidazoleacetate (fold
change = 0.63; P = 0.03) were all decreased in RES compared with CON.

Maternal restricted-feeding alters offspring lipid metabolism
Maternal restricted-nutrition caused reductions to offspring lysophosphlipids at all time
points (Figure 20). At d 90, 1-palmitoyl-GPE (16:0; fold change = 0.81; P = 0.04) and 1stearoyl-GPE (18:0; fold change = 0.83; P = 0.05) were decreased in RES compared with CON.
At d 135, 1-stearoyl-GPE (18:0; fold change = 0.68; P = 0.001), 1-stearoyl-GPE (18:0; fold
change = 0.51; P = 0.00001), and 1-stearoyl-GPI (18:0; fold change = 0.58; P = 0.0003) were
decreased in RES compared with CON. At birth, 1-palmitoyl-GPC (16:0; fold change = 0.75; P
= 0.002), 1-palmitoleoyl-GPC (16:1; fold change = 0.72; P = 0.0007), 1-stearoyl-GPC (18:0;
fold change = 0.81; P = 0.02), 1-oleoyl-GPC (18:1; fold change = 0.83; P = 0.009), 1-palmitoylGPE (16:0; fold change = 0.80; P = 0.05), 1-stearoyl-GPE (18:0; fold change = 0.70; P =
0.0001), and 1-oleoyl-GPE (18:1; fold change = 0.84; P = 0.02) were all decreased in RES
compared with CON.
Restricted-feeding cause changes in offspring phosphatidylcholine metabolism at all
time points (Figure 21). 1-palmitoyl-2-oleoyl-GPC (16:0/18:1; fold change = 0.84; P = 0.005), 1palmitoyl-2-linoleoyl-GPC (16:0/18:2; fold change = 0.84; P = 0.01), 1-palmitoyl-2-dihomolinolenoyl-GPC (16:0/20:3n3 or 6; fold change = 0.66; P = 0.0002), 1-stearoyl-2-oleoyl-GPC
(18:0/18:1; fold change = 0.75; P = 0.004), and 1,2-dioleoyl-GPC (18:1/18:1; fold change =
0.86; P = 0.008) were all reduced at d 90 in RES compared with CON. At d 135, 1-palmitoyl-2palmitoleoyl-GPC (16:0/16:1; fold change = 0.84; P = 0.04) was decreased and 1-palmitoleoyl2-linolenoyl-GPC (16:1/18:3; fold change = 1.39; P = 0.04) was increased in RES compared
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with CON. Additionally, at birth, 1-myristoyl-2-palmitoyl-GPC (14:0/16:0; fold change = 0.81;
P = 0.03), 1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1; fold change = 0.76; P = 0.002), 1palmitoyl-2-oleoyl-GPC (16:0/18:1; fold change = 0.87; P = 0.03), and 1-palmitoyl-2-dihomolinolenoyl-GPC (16:0/20:3n3 or 6; fold change = 0.81; P = 0.04) were all decreased in RES
compared with CON.
There were also changes in phosphatidylethanolamine metabolism in response to
maternal restricted-nutrition (Figure 22). At d 90, 1-palmitoyl-2-oleoyl-GPE (16:0/18:1; fold
change = 0.73; P = 0.007), 1-palmitoleoyl-2-oleoyl-GPE (16:1/18:1; fold change = 0.72; P =
0.02), 1-stearoyl-2-oleoyl-GPE (18:0/18:1; fold change = 0.70; P = 0.007), and 1,2-dioleoyl-GPE
(18:1/18:1; fold change = 0.77; P = 0.01) were reduced in RES compared with CON. Despite
seeing no changes to any metabolites at d 135, 1-palmitoleoyl-2-oleoyl-GPE (16:1/18:1; fold
change = 0.75; P = 0.03) was again reduced at birth in RES compared with CON.
Finally, restricted-feeding resulted in broad changes to offspring sphingolipid
metabolism, especially at d 90 (Figure 23). Myristoyl dihydrosphingomyelin (d18:0/14:0; fold
change = 0.71; P = 0.01), palmitoyl dihydrosphingomyelin (d18:0/16:0; fold change = 0.65; P =
0.0004), palmitoyl sphingomyelin (d18:1/16:0; fold change = 0.84; P = 0.005), stearoyl
sphingomyelin (d18:1/18:0; fold change = 0.82; P = 0.008), behenoyl sphingomyelin
(d18:1/22:0; fold change = 0.56; P = 0.0002), tricosanoyl sphingomyelin (d18:1/23:0; fold
change = 0.50; P = 0.0004), lignoceroyl sphingomyelin (d18:1/24:0; fold change = 0.55; P =
0.0007), sphingomyelin (d18:1/17:0, d17:1/18:0, d19:1/16:0; fold change = 0.75; P = 0.009),
sphingomyelin (d18:1/20:0, d16:1/22:0; fold change = 0.65; P = 0.003), sphingomyelin
(d18:1/20:1, d18:2/20:0; fold change = 0.73; P = 0.007), sphingomyelin (d18:1/22:1, d18:2/22:0,
d16:1/24:1; fold change = 0.68; P = 0.002), sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1;
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fold change = 0.68; P = 0.03), sphingomyelin (d18:1/24:1, d18:2/24:0; fold change = 0.64; P =
0.006), sphingomyelin (d18:2/24:1, d18:1/24:2; fold change = 0.77; P = 0.03), sphingomyelin
(d18:0/18:0, d19:0/17:0; fold change = 0.58; P = 0.001), and sphingomyelin (d18:1/19:0,
d19:1/18:0; fold change = 0.57; P = 0.02) were decreased at d 90 in RES compared with CON.
At d 135, sphingomyelin (d18:2/14:0, d18:1/14:1; fold change = 1.24; P = 0.02) and
sphingomyelin (d18:2/24:2; fold change = 2.02; P = 0.002) were increased, whereas at birth,
sphingomyelin (d18:1/20:1, d18:2/20:0; fold change = 0.80; P = 0.007) and sphingomyelin
(d18:1/19:0, d19:1/18:0; fold change = 0.61; P = 0.04) were decreased in RES compared with
CON.
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Figure 1: Serum from offspring of poorly nourished ewes does not alter C2C12 proliferation.
C2C12 cells were cultured in serum collected from offspring of CON (n = 6), RES (n = 6), or OVER (n =
6) ewes at birth. Percentage of cells in s-phase was measured by 5-bromo-2'-deoxyuridine (BrdU)
incorporation in C2C12 cells cultured in offspring serum for 48 hours. Cells were cultured in duplicate

wells, and the experiment was replicated once. Data are presented as mean ± standard error.
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Figure 2: Serum from offspring of poorly nourished ewes does not alter C2C12
differentiation. C2C12 cells were cultured in serum collected from offspring of CON (n = 6), RES (n =
6), or OVER (n = 6) ewes at birth. The fusion index (A) and myofiber diameter (B) of differentiated

C2C12 myofibers cultured in offspring serum for 5 days were calculated. Cells were cultured in
duplicate wells, and the experiment was replicated once. Data are presented as mean ± standard
error.
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Figure 3: Serum from offspring born to restricted-fed ewes alters C2C12 mitochondrial
respiration. C2C12 cells were cultured in serum collected from offspring of CON (n = 6), RES (n = 6),
or OVER (n = 6) ewes at birth. (A) Oxygen Consumption Rate (OCR), an indicator of oxygen-

dependent mitochondrial ATP production, was measured when C2C12 cells were successively
exposed to oligomycin, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), and
rotenone/antimycin. (B) Calculation of non-mitochondrial respiration, basal respiration, proton
leak, ATP production, maximal respiration, and spare respiratory capacity of C2C12. Data are
presented as mean ± standard error. * denotes P ≤ 0.05 compared with CON.
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Figure 4: Serum from offspring of poorly nourished ewes does not alter C2C12 glycolytic
function. C2C12 cells were cultured in serum collected from offspring of control-fed (CON, n =
6), restricted (RES, n = 6), or over-fed (OVER, n = 6) ewes at birth. Extracellular Acidification
Rate (ECAR), an indication of glycolysis, was measured when C2C12 cells were sequentially
exposed to glucose, oligomycin, and 2-deoxy-D-glucose (2-DG).
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Table 1. Number of fetal metabolites in LD altered by maternal diet.
Metabolites

Metabolites

P ≤ 0.05

0.05 < P ≤ 0.1

Diet

Time

Total

Increased

Decreased

Total

Increased

Decreased

RES/CON

d 90

86

19

67

35

9

26

d 135

72

22

50

28

6

22

Birth

64

14

50

41

12

29

d 90

78

49

29

30

20

10

d 135

27

18

9

22

13

9

Birth

102

15

87

50

9

41

d 90

104

20

84

39

9

30

d 135

118

38

80

38

13

25

Birth

117

85

32

56

44

12

OVER/CON

RES/OVER

1

Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet.
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes
allowed to undergo parturition.
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Table 2. Number of fetal metabolites in LD altered by day of gestation.
Metabolites

Metabolites

P ≤ 0.05

0.05 < P ≤ 0.1

Diet

Time

Total

Increased

Decreased

Total

Increased

Decreased

CON

d 90/d 135

362

200

162

28

15

13

d 90/Birth

436

191

245

29

13

16

d 135/Birth

374

127

247

35

17

18

d 90/d 135

376

211

165

31

15

16

d 90/Birth

441

189

252

32

15

17

d 135/Birth

374

129

245

33

17

16

d 90/d 135

374

219

155

51

38

13

d 90/Birth

441

230

211

20

11

9

d 135/Birth

365

160

205

42

16

26

RES

OVER

1

Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet.
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes
allowed to undergo parturition.
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Table 3. Number of metabolites in major pathways altered by treatment.
Major Metabolic
Pathway

Total Number of
Metabolites in Pathway

Pathway Metabolites
Altered in OVER vs.
CON

Pathway Metabolites
Altered in RES vs.
CON

Amino Acid

161

63

53

Peptide

17

6

4

Carbohydrate

39

12

8

Energy

11

1

1

Lipid

268

70

89

Nucleotide

56

10

16

Cofactors and Vitamins

31

15

12

Xenobiotics

29

10

13

1

Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet.
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes
allowed to undergo parturition.
Significance is determined at P ≤ 0.05 compared with CON. Total number of metabolites is
determined from combining d 90, d 135, and birth time-points.
2
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D 90

Birth

D 135

Group
Color by PARAM_TREATMENT
CP
Control
NC
Restricted
Overfed
Shape by time long
Day 135
Day 90
Birth

Figure 5: Principle Component Analysis (PCA) and hierarchical clustering obtained from
employing metabolic concentration of all metabolites detected in LD tissue. PCA of LD
samples indicates that time is the primary driver of variance between samples. LD samples (n = 8
per treatment per time point) were collected from offspring born to ewes fed CON, RES, or
OVER diets at d 90, 135 of gestation, or within 24 hours of birth were analyzed by UPLCMS/MS.
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Table 4: Pathways altered by treatment across time.
Pathway Metabolites
Significant
(k)

Detected
(m)

Significant/
Detected
(k/m)

Enrichment 1
(k/m)/(n/N)

Acetylated Peptides

1

1

1

5.37

Bacterial/Fungal

1

1

1

5.37

Ketone Bodies

1

1

1

5.37

Riboflavin Metabolism

2

2

1

5.37

Tocopherol Metabolism

1

1

1

5.37

Vitamin A Metabolism

1

1

1

5.37

Medium Chain Fatty Acid

3

5

0.6

3.22

Fatty Acid Metabolism (also BCAA Metabolism)

1

2

0.5

2.68

Pentose Phosphate Pathway

1

2

0.5

2.68

Primary Bile Acid Metabolism

3

6

0.5

2.68

Pyrimidine Metabolism, Thymine containing

1

2

0.5

2.68

Vitamin B6 Metabolism

1

2

0.5

2.68

Sphingolipid Metabolism

15

31

0.48

2.6

Lysophospholipid

11

24

0.46

2.46

Phosphatidylethanolamine

5

11

0.45

2.44

Histidine Metabolism

6

14

0.43

2.3

Chemical

2

5

0.4

2.15

Hemoglobin and Porphyrin Metabolism

2

5

0.4

2.15

Nucleotide Sugar

2

5

0.4

2.15

Urea cycle; Arginine and Proline Metabolism

6

16

0.38

2.01

Pantothenate and CoA Metabolism

1

3

0.33

1.79

Benzoate Metabolism

3

10

0.3

1.61

Glutathione Metabolism

3

10

0.3

1.61

Nicotinate and Nicotinamide Metabolism

3

10

0.3

1.61

Plasmalogen

3

10

0.3

1.61

Methionine, Cysteine, SAM and Taurine Metabolism

5

17

0.29

1.58

Glycine, Serine and Threonine Metabolism

3

11

0.27

1.46

Pathway Name
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1

Alanine and Aspartate Metabolism

2

8

0.25

1.34

Food Component/Plant

3

13

0.23

1.24

Gamma-glutamyl Amino Acid

3

13

0.23

1.24

Glutamate Metabolism

3

13

0.23

1.24

Fatty Acid, Dicarboxylate

2

9

0.22

1.19

Lysoplasmalogen

1

5

0.2

1.07

Phosphatidylcholine

3

17

0.18

0.95

Lysine Metabolism

2

12

0.17

0.89

Fructose, Mannose and Galactose Metabolism

1

7

0.14

0.77

Tyrosine Metabolism

1

7

0.14

0.77

Purine Metabolism, (Hypo) Xanthine/Inosine containing

1

11

0.09

0.49

Tryptophan Metabolism

1

11

0.09

0.49

Leucine, Isoleucine and Valine Metabolism

2

24

0.08

0.45

Pyrimidine Metabolism, Uracil containing

1

12

0.08

0.45

Fatty Acid Metabolism (Acyl Carnitine)

1

34

0.03

0.16

All compounds; Significant (n) = 114, Detected (N) = 612, Significant/ detected (n/N) = 0.19

2

Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet.
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes
allowed to undergo parturition.
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Table 5: Pathways altered by treatment.
Pathway Metabolites
Significant
(k)

Detected
(m)

Significant/
Detected
(k/m)

Enrichment 1
(k/m)/(n/N)

Acetylated Peptides

1

1

1

4.6

Advanced Glycation End-product

1

1

1

4.6

Bacterial/Fungal

1

1

1

4.6

Phosphatidylglycerol

1

1

1

4.6

Thiamine Metabolism

2

2

1

4.6

Phosphatidylethanolamine

7

11

0.64

2.93

Carnitine Metabolism

1

2

0.5

2.3

Guanidino and Acetamido Metabolism

1

2

0.5

2.3

Histidine Metabolism

7

14

0.5

2.3

Primary Bile Acid Metabolism

3

6

0.5

2.3

Pyrimidine Metabolism, Orotate containing

1

2

0.5

2.3

Secondary Bile Acid Metabolism

2

4

0.5

2.3

Methionine, Cysteine, SAM and Taurine Metabolism

8

17

0.47

2.17

Phosphatidylcholine

8

17

0.47

2.17

Food Component/Plant

6

13

0.46

2.12

Glutamate Metabolism

6

13

0.46

2.12

Aminosugar Metabolism

3

7

0.43

1.97

Tyrosine Metabolism

3

7

0.43

1.97

Lysophospholipid

10

24

0.42

1.92

Hemoglobin and Porphyrin Metabolism

2

5

0.4

1.84

Lysoplasmalogen

2

5

0.4

1.84

Glycine, Serine and Threonine Metabolism

4

11

0.36

1.67

Dipeptide

1

3

0.33

1.53

Inositol Metabolism

1

3

0.33

1.53

Phenylalanine Metabolism

1

3

0.33

1.53

Benzoate Metabolism

3

10

0.3

1.38

Nicotinate and Nicotinamide Metabolism

3

10

0.3

1.38

Pathway Name
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1

Plasmalogen

3

10

0.3

1.38

Purine Metabolism, (Hypo) Xanthine/Inosine
containing

3

11

0.27

1.25

Alanine and Aspartate Metabolism

2

8

0.25

1.15

Polyunsaturated Fatty Acid (n3 and n6)

3

12

0.25

1.15

Gamma-glutamyl Amino Acid

3

13

0.23

1.06

Polyamine Metabolism

2

9

0.22

1.02

Ascorbate and Aldarate Metabolism

1

5

0.2

0.92

Chemical

1

5

0.2

0.92

Endocannabinoid

1

5

0.2

0.92

Medium Chain Fatty Acid

1

5

0.2

0.92

Phospholipid Metabolism

2

10

0.2

0.92

Urea cycle; Arginine and Proline Metabolism

3

16

0.19

0.86

Tryptophan Metabolism

2

11

0.18

0.84

Leucine, Isoleucine and Valine Metabolism

4

24

0.17

0.77

Fructose, Mannose and Galactose Metabolism

1

7

0.14

0.66

Progestin Steroids

1

7

0.14

0.66

Fatty Acid, Dicarboxylate

1

9

0.11

0.51

Ceramides

1

10

0.1

0.46

Glutathione Metabolism

1

10

0.1

0.46

Pyrimidine Metabolism, Cytidine containing

1

10

0.1

0.46

Sphingolipid Metabolism

3

31

0.1

0.45

Purine Metabolism, Adenine containing

1

11

0.09

0.42

Lysine Metabolism

1

12

0.08

0.38

Fatty Acid Metabolism (Acyl Carnitine)

2

34

0.06

0.27

All compounds; Significant (n) = 133, Detected (N) = 612, Significant/ detected (n/N) = 0.22

2

Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet.
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes
allowed to undergo parturition.
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Table 6: Pathways altered by time.
Pathway Metabolites
Significant
(k)

Detected
(m)

Significant/
Detected
(k/m)

Enrichment 1
(k/m)/(n/N)

Acetylated Peptides

1

1

1

1.07

Advanced Glycation End-product

1

1

1

1.07

Alanine and Aspartate Metabolism

8

8

1

1.07

Aminosugar Metabolism

7

7

1

1.07

Ascorbate and Aldarate Metabolism

5

5

1

1.07

Bacterial/Fungal

1

1

1

1.07

Carnitine Metabolism

2

2

1

1.07

Ceramides

10

10

1

1.07

Chemical

5

5

1

1.07

Corticosteroids

1

1

1

1.07

Creatine Metabolism

4

4

1

1.07

Diacylglycerol

9

9

1

1.07

Dipeptide

3

3

1

1.07

Endocannabinoid

5

5

1

1.07

Fatty Acid Metabolism

1

1

1

1.07

Fatty Acid Metabolism (Acyl Choline)

1

1

1

1.07

Fatty Acid Metabolism (also BCAA Metabolism)

2

2

1

1.07

Fatty Acid Metabolism (Acyl Carnitine)

34

34

1

1.07

Fatty Acid Metabolism (Acyl Glycine)

2

2

1

1.07

Fatty Acid Synthesis

2

2

1

1.07

Fatty Acid, Amino

1

1

1

1.07

Fatty Acid, Branched

2

2

1

1.07

Fatty Acid, Monohydroxy

5

5

1

1.07

Food Component/Plant

13

13

1

1.07

Gamma-glutamyl Amino Acid

13

13

1

1.07

Glutamate Metabolism

13

13

1

1.07

Glycerolipid Metabolism

3

3

1

1.07

Pathway Name

56

Glycine, Serine and Threonine Metabolism

11

11

1

1.07

Guanidino and Acetamido Metabolism

2

2

1

1.07

Hemoglobin and Porphyrin Metabolism

5

5

1

1.07

Inositol Metabolism

3

3

1

1.07

Ketone Bodies

1

1

1

1.07

Medium Chain Fatty Acid

5

5

1

1.07

Mevalonate Metabolism

1

1

1

1.07

Monoacylglycerol

9

9

1

1.07

Nicotinate and Nicotinamide Metabolism

10

10

1

1.07

Pantothenate and CoA Metabolism

3

3

1

1.07

Phenylalanine Metabolism

3

3

1

1.07

Phosphatidylethanolamine

11

11

1

1.07

Phosphatidylglycerol

1

1

1

1.07

Phosphatidylinositol

2

2

1

1.07

Phosphatidylserine

3

3

1

1.07

Polyamine Metabolism

9

9

1

1.07

Polyunsaturated Fatty Acid (n3 and n6)

12

12

1

1.07

Pregnenolone Steroids

3

3

1

1.07

Progestin Steroids

7

7

1

1.07

Purine and Pyrimidine Metabolism

1

1

1

1.07

Purine Metabolism, Guanine containing

7

7

1

1.07

Pyrimidine Metabolism, Orotate containing

2

2

1

1.07

Pyrimidine Metabolism, Thymine containing

2

2

1

1.07

Pyrimidine Metabolism, Uracil containing

12

12

1

1.07

Riboflavin Metabolism

2

2

1

1.07

TCA Cycle

9

9

1

1.07

Thiamine Metabolism

2

2

1

1.07

Tocopherol Metabolism

1

1

1

1.07

Tyrosine Metabolism

7

7

1

1.07

Vitamin A Metabolism

1

1

1

1.07

Vitamin B6 Metabolism

2

2

1

1.07
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1

Leucine, Isoleucine and Valine Metabolism

23

24

0.96

1.02

Lysophospholipid

23

24

0.96

1.02

Methionine, Cysteine, SAM and Taurine Metabolism

16

17

0.94

1

Phosphatidylcholine

16

17

0.94

1

Urea cycle; Arginine and Proline Metabolism

15

16

0.94

1

Histidine Metabolism

13

14

0.93

0.99

Lysine Metabolism

11

12

0.92

0.98

Glycolysis, Gluconeogenesis, and Pyruvate Metabolism

10

11

0.91

0.97

Purine Metabolism, (Hypo) Xanthine/Inosine containing

10

11

0.91

0.97

Purine Metabolism, Adenine containing

10

11

0.91

0.97

Sphingolipid Metabolism

28

31

0.9

0.96

Benzoate Metabolism

9

10

0.9

0.96

Phospholipid Metabolism

9

10

0.9

0.96

Plasmalogen

9

10

0.9

0.96

Pyrimidine Metabolism, Cytidine containing

9

10

0.9

0.96

Fatty Acid, Dicarboxylate

8

9

0.89

0.95

Long Chain Fatty Acid

10

12

0.83

0.89

Pentose Metabolism

5

6

0.83

0.89

Glutathione Metabolism

8

10

0.8

0.85

Lysoplasmalogen

4

5

0.8

0.85

Nucleotide Sugar

4

5

0.8

0.85

Secondary Bile Acid Metabolism

3

4

0.75

0.8

Tryptophan Metabolism

8

11

0.73

0.78

Fructose, Mannose and Galactose Metabolism

5

7

0.71

0.76

Oxidative Phosphorylation

1

2

0.5

0.53

Pentose Phosphate Pathway

1

2

0.5

0.53

Primary Bile Acid Metabolism

3

6

0.5

0.53

All compounds; Significant (n) = 574, Detected (N) = 612, Significant/ detected (n/N) = 0.94

2

Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet.
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was
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performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes
allowed to undergo parturition.
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Table 7: Pathways altered at d 90 in RES compared with CON.
Pathway Metabolites
Significant
(k)

Detected
(m)

Significant/
Detected
(k/m)

Enrichment 1
(k/m)/(n/N)

Advanced Glycation End-product

1

1

1

7.12

Ceramides

7

10

0.7

4.98

Sphingolipid Metabolism

16

31

0.52

3.67

Plasmalogen

5

10

0.5

3.56

Thiamine Metabolism

1

2

0.5

3.56

Nucleotide Sugar

2

5

0.4

2.85

Food Component/Plant

5

13

0.38

2.74

Phosphatidylethanolamine

4

11

0.36

2.59

Inositol Metabolism

1

3

0.33

2.37

Pantothenate and CoA Metabolism

1

3

0.33

2.37

Primary Bile Acid Metabolism

2

6

0.33

2.37

Benzoate Metabolism

3

10

0.3

2.13

Nicotinate and Nicotinamide Metabolism

3

10

0.3

2.13

Pyrimidine Metabolism, Cytidine containing

3

10

0.3

2.13

Phosphatidylcholine

5

17

0.29

2.09

Glutathione Metabolism

2

10

0.2

1.42

Lysoplasmalogen

1

5

0.2

1.42

Medium Chain Fatty Acid

1

5

0.2

1.42

Pyrimidine Metabolism, Uracil containing

2

12

0.17

1.19

Glutamate Metabolism

2

13

0.15

1.09

Tyrosine Metabolism

1

7

0.14

1.02

Alanine and Aspartate Metabolism

1

8

0.12

0.89

Lysophospholipid

3

24

0.12

0.89

Methionine, Cysteine, SAM and Taurine Metabolism

2

17

0.12

0.84

Fatty Acid, Dicarboxylate

1

9

0.11

0.79

Polyamine Metabolism

1

9

0.11

0.79

Glycine, Serine and Threonine Metabolism

1

11

0.09

0.65

Pathway Name
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1

Tryptophan Metabolism

1

11

0.09

0.65

Fatty Acid Metabolism (Acyl Carnitine)

3

34

0.09

0.63

Leucine, Isoleucine and Valine Metabolism

2

24

0.08

0.59

Lysine Metabolism

1

12

0.08

0.59

Polyunsaturated Fatty Acid (n3 and n6)

1

12

0.08

0.59

Urea cycle; Arginine and Proline Metabolism

1

16

0.06

0.44

All compounds; Significant (n) = 86, Detected (N) = 612, Significant/ detected (n/N) = 0.14

2

Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet.
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes
allowed to undergo parturition.
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Table 8: Pathways altered at d 135 in RES compared with CON.
Pathway Metabolites
Significant
(k)

Detected
(m)

Significant/
Detected
(k/m)

Enrichment 1
(k/m)/(n/N)

Bacterial/Fungal

1

1

1

8.5

Ketone Bodies

1

1

1

8.5

Phosphatidylglycerol

1

1

1

8.5

Riboflavin Metabolism

2

2

1

8.5

Histidine Metabolism

7

14

0.5

4.25

Pyrimidine Metabolism, Thymine containing

1

2

0.5

4.25

Secondary Bile Acid Metabolism

2

4

0.5

4.25

Hemoglobin and Porphyrin Metabolism

2

5

0.4

3.4

Glycerolipid Metabolism

1

3

0.33

2.83

Gamma-glutamyl Amino Acid

4

13

0.31

2.62

Tyrosine Metabolism

2

7

0.29

2.43

Glycine, Serine and Threonine Metabolism

3

11

0.27

2.32

Alanine and Aspartate Metabolism

2

8

0.25

2.13

Lysophospholipid

6

24

0.25

2.13

Methionine, Cysteine, SAM and Taurine Metabolism

4

17

0.24

2

Fatty Acid, Dicarboxylate

2

9

0.22

1.89

Polyamine Metabolism

2

9

0.22

1.89

Chemical

1

5

0.2

1.7

Glutathione Metabolism

2

10

0.2

1.7

Lysoplasmalogen

1

5

0.2

1.7

Phospholipid Metabolism

2

10

0.2

1.7

Urea cycle; Arginine and Proline Metabolism

3

16

0.19

1.59

Primary Bile Acid Metabolism

1

6

0.17

1.42

Food Component/Plant

2

13

0.15

1.31

Aminosugar Metabolism

1

7

0.14

1.21

Progestin Steroids

1

7

0.14

1.21

Phosphatidylcholine

2

17

0.12

1

Pathway Name
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1

TCA Cycle

1

9

0.11

0.94

Benzoate Metabolism

1

10

0.1

0.85

Plasmalogen

1

10

0.1

0.85

Glycolysis, Gluconeogenesis, and Pyruvate
Metabolism

1

11

0.09

0.77

Purine Metabolism, (Hypo) Xanthine/Inosine
containing

1

11

0.09

0.77

Tryptophan Metabolism

1

11

0.09

0.77

Lysine Metabolism

1

12

0.08

0.71

Polyunsaturated Fatty Acid (n3 and n6)

1

12

0.08

0.71

Pyrimidine Metabolism, Uracil containing

1

12

0.08

0.71

Glutamate Metabolism

1

13

0.08

0.65

Sphingolipid Metabolism

2

31

0.06

0.55

Leucine, Isoleucine and Valine Metabolism

1

24

0.04

0.35

All compounds; Significant (n) = 72, Detected (N) = 612, Significant/ detected (n/N) = 0.12

2

Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet.
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes
allowed to undergo parturition.
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Table 9: Pathways altered at birth in RES compared with CON.
Pathway Metabolites
Significant
(k)

Detected
(m)

Significant/
Detected
(k/m)

Enrichment 1
(k/m)/(n/N)

Phosphatidylglycerol

1

1

1

9.56

Purine and Pyrimidine Metabolism

1

1

1

9.56

Tocopherol Metabolism

1

1

1

9.56

Phenylalanine Metabolism

2

3

0.67

6.37

Nucleotide Sugar

3

5

0.6

5.74

Guanidino and Acetamido Metabolism

1

2

0.5

4.78

Pyrimidine Metabolism, Orotate containing

1

2

0.5

4.78

Thiamine Metabolism

1

2

0.5

4.78

Lysophospholipid

10

24

0.42

3.98

Alanine and Aspartate Metabolism

3

8

0.38

3.59

Histidine Metabolism

4

14

0.29

2.73

Progestin Steroids

2

7

0.29

2.73

Secondary Bile Acid Metabolism

1

4

0.25

2.39

Phosphatidylcholine

4

17

0.24

2.25

Food Component/Plant

3

13

0.23

2.21

Lysoplasmalogen

1

5

0.2

1.91

Nicotinate and Nicotinamide Metabolism

2

10

0.2

1.91

Pyrimidine Metabolism, Cytidine containing

2

10

0.2

1.91

Primary Bile Acid Metabolism

1

6

0.17

1.59

Pyrimidine Metabolism, Uracil containing

2

12

0.17

1.59

Glutamate Metabolism

2

13

0.15

1.47

Fructose, Mannose and Galactose Metabolism

1

7

0.14

1.37

Urea cycle; Arginine and Proline Metabolism

2

16

0.12

1.2

Methionine, Cysteine, SAM and Taurine Metabolism

2

17

0.12

1.12

Fatty Acid, Dicarboxylate

1

9

0.11

1.06

Monoacylglycerol

1

9

0.11

1.06

Phosphatidylethanolamine

1

11

0.09

0.87

Pathway Name
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1

Purine Metabolism, (Hypo) Xanthine/Inosine containing

1

11

0.09

0.87

Purine Metabolism, Adenine containing

1

11

0.09

0.87

Tryptophan Metabolism

1

11

0.09

0.87

Fatty Acid Metabolism (Acyl Carnitine)

3

34

0.09

0.84

Sphingolipid Metabolism

2

31

0.06

0.62

All compounds; Significant (n) = 64, Detected (N) = 612, Significant/ detected (n/N) = 0.10

2

Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet.
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes
allowed to undergo parturition.
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Table 10: Pathways altered at d 90 in OVER compared with CON.
Pathway Metabolites
Significant
(k)

Detected
(m)

Significant/
Detected
(k/m)

Enrichment 1
(k/m)/(n/N)

Acetylated Peptides

1

1

1

7.85

Fatty Acid, Amino

1

1

1

7.85

Pyrimidine Metabolism, Thymine containing

2

2

1

7.85

Pantothenate and CoA Metabolism

2

3

0.67

5.23

Nucleotide Sugar

3

5

0.6

4.71

Tyrosine Metabolism

4

7

0.57

4.48

Pentose Phosphate Pathway

1

2

0.5

3.92

Riboflavin Metabolism

1

2

0.5

3.92

Thiamine Metabolism

1

2

0.5

3.92

Vitamin B6 Metabolism

1

2

0.5

3.92

Alanine and Aspartate Metabolism

3

8

0.38

2.94

Dipeptide

1

3

0.33

2.62

Primary Bile Acid Metabolism

2

6

0.33

2.62

Glutathione Metabolism

3

10

0.3

2.35

Histidine Metabolism

4

14

0.29

2.24

Glycine, Serine and Threonine Metabolism

3

11

0.27

2.14

Purine Metabolism, Adenine containing

3

11

0.27

2.14

Tryptophan Metabolism

3

11

0.27

2.14

Secondary Bile Acid Metabolism

1

4

0.25

1.96

Food Component/Plant

3

13

0.23

1.81

Gamma-glutamyl Amino Acid

3

13

0.23

1.81

Glutamate Metabolism

3

13

0.23

1.81

Leucine, Isoleucine and Valine Metabolism

5

24

0.21

1.63

Ascorbate and Aldarate Metabolism

1

5

0.2

1.57

Chemical

1

5

0.2

1.57

Hemoglobin and Porphyrin Metabolism

1

5

0.2

1.57

Urea cycle; Arginine and Proline Metabolism

3

16

0.19

1.47

Pathway Name
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1

Glycolysis, Gluconeogenesis, and Pyruvate Metabolism

2

11

0.18

1.43

Long Chain Fatty Acid

2

12

0.17

1.31

Fructose, Mannose and Galactose Metabolism

1

7

0.14

1.12

Methionine, Cysteine, SAM and Taurine Metabolism

2

17

0.12

0.92

TCA Cycle

1

9

0.11

0.87

Benzoate Metabolism

1

10

0.1

0.78

Nicotinate and Nicotinamide Metabolism

1

10

0.1

0.78

Purine Metabolism, (Hypo) Xanthine/Inosine containing

1

11

0.09

0.71

Lysine Metabolism

1

12

0.08

0.65

Lysophospholipid

2

24

0.08

0.65

Pyrimidine Metabolism, Uracil containing

1

12

0.08

0.65

Sphingolipid Metabolism

2

31

0.06

0.51

Phosphatidylcholine

1

17

0.06

0.46

All compounds; Significant (n) = 78, Detected (N) = 612, Significant/ detected (n/N) = 0.13

2

Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet.
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes
allowed to undergo parturition.
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Table 11: Pathways altered at d 135 in OVER compared with CON.
Pathway Metabolites
Pathway Name

1

Enrichment
(k/m)/(n/N)

Significant
(k)

Detected
(m)

Significant/
Detected
(k/m)

Bacterial/Fungal

1

1

1

22.67

Pyrimidine Metabolism, Orotate containing

1

2

0.5

11.33

Fatty Acid, Dicarboxylate

2

9

0.22

5.04

Endocannabinoid

1

5

0.2

4.53

Hemoglobin and Porphyrin Metabolism

1

5

0.2

4.53

Lysoplasmalogen

1

5

0.2

4.53

Nicotinate and Nicotinamide Metabolism

2

10

0.2

4.53

Methionine, Cysteine, SAM and Taurine Metabolism

3

17

0.18

4

Histidine Metabolism

2

14

0.14

3.24

Tyrosine Metabolism

1

7

0.14

3.24

Alanine and Aspartate Metabolism

1

8

0.12

2.83

Leucine, Isoleucine and Valine Metabolism

3

24

0.12

2.83

Phosphatidylcholine

2

17

0.12

2.67

Benzoate Metabolism

1

10

0.1

2.27

Glutathione Metabolism

1

10

0.1

2.27

Phosphatidylethanolamine

1

11

0.09

2.06

Tryptophan Metabolism

1

11

0.09

2.06

Food Component/Plant

1

13

0.08

1.74

Urea cycle; Arginine and Proline Metabolism

1

16

0.06

1.42

1

All compounds; Significant (n) = 27, Detected (N) = 612, Significant/ detected (n/N) = 0.04

2

Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet.
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes
allowed to undergo parturition.
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Table 12: Pathways altered at birth in OVER compared with CON.
Pathway Compounds
Significant
(k)

Detected
(m)

Significant/
Detected
(k/m)

Enrichment 1
(k/m)/(n/N)

Acetylated Peptides

1

1

1

6

Advanced Glycation End-product

1

1

1

6

Fatty Acid Metabolism (Acyl Choline)

1

1

1

6

Phosphatidylglycerol

1

1

1

6

Riboflavin Metabolism

2

2

1

6

Tocopherol Metabolism

1

1

1

6

Vitamin A Metabolism

1

1

1

6

Phosphatidylethanolamine

10

11

0.91

5.45

Alanine and Aspartate Metabolism

6

8

0.75

4.5

Inositol Metabolism

2

3

0.67

4

Lysophospholipid

13

24

0.54

3.25

Fatty Acid Metabolism (also BCAA Metabolism)

1

2

0.5

3

Phosphatidylinositol

1

2

0.5

3

Polyamine Metabolism

4

9

0.44

2.67

Lysoplasmalogen

2

5

0.4

2.4

Phenylalanine Metabolism

1

3

0.33

2

Fatty Acid Metabolism (Acyl Carnitine)

11

34

0.32

1.94

Aminosugar Metabolism

2

7

0.29

1.71

Glycine, Serine and Threonine Metabolism

3

11

0.27

1.64

Methionine, Cysteine, SAM and Taurine Metabolism

4

17

0.24

1.41

Phosphatidylcholine

4

17

0.24

1.41

Chemical

1

5

0.2

1.2

Hemoglobin and Porphyrin Metabolism

1

5

0.2

1.2

Medium Chain Fatty Acid

1

5

0.2

1.2

Nucleotide Sugar

1

5

0.2

1.2

Plasmalogen

2

10

0.2

1.2

Urea cycle; Arginine and Proline Metabolism

3

16

0.19

1.12

Pathway Name
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1

Tryptophan Metabolism

2

11

0.18

1.09

Lysine Metabolism

2

12

0.17

1

Gamma-glutamyl Amino Acid

2

13

0.15

0.92

Fatty Acid, Dicarboxylate

1

9

0.11

0.67

Benzoate Metabolism

1

10

0.1

0.6

Ceramides

1

10

0.1

0.6

Glutathione Metabolism

1

10

0.1

0.6

Phospholipid Metabolism

1

10

0.1

0.6

Sphingolipid Metabolism

3

31

0.1

0.58

Glycolysis, Gluconeogenesis, and Pyruvate Metabolism

1

11

0.09

0.55

Purine Metabolism, (Hypo)Xanthine/Inosine containing

1

11

0.09

0.55

Polyunsaturated Fatty Acid (n3 and n6)

1

12

0.08

0.5

Pyrimidine Metabolism, Uracil containing

1

12

0.08

0.5

Food Component/Plant

1

13

0.08

0.46

Glutamate Metabolism

1

13

0.08

0.46

Histidine Metabolism

1

14

0.07

0.43

All compounds; Significant (n) = 102, Detected (N) = 612, Significant/ detected (n/N) = 0.17

2

Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet.
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes
allowed to undergo parturition.
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Figure 6: Over-feeding during gestation increased offspring advanced glycation end
products at birth. Offspring metabolites from advanced glycation end products were altered in
OVER compared with CON. LD collected from offspring born to ewes fed CON, RES, or OVER
diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was analyzed by UPLCMS/MS. Data are presented as fold change ± standard error. * denotes P ≤ 0.05 compared with
CON.
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Figure 7: Over-feeding during gestation alters offspring alanine and aspartate metabolism
at multiple time points of gestation. Offspring metabolites involved in alanine and aspartate
metabolism were altered in OVER compared with CON. LD collected from offspring born to
ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth
(C) was analyzed by UPLC-MS/MS. Data are presented as fold change ± standard error. *
denotes P ≤ 0.05 compared with CON.
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Figure 8: Over-feeding during gestation alters offspring glutathione metabolism at multiple
time points of gestation. Offspring metabolites involved in glutathione metabolism were altered
in OVER compared with CON. LD collected from offspring born to ewes fed CON, RES, or
OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was analyzed by
UPLC-MS/MS. Data are presented as fold change ± standard error. * denotes P ≤ 0.05 compared
with CON.
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Figure 9: Over-feeding during gestation alters offspring histidine metabolism at multiple
time points of gestation. Offspring metabolites involved histidine metabolism were altered in
OVER compared with CON. LD collected from offspring born to ewes fed CON, RES, or OVER
diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was analyzed by UPLCMS/MS. Data are presented as fold change ± standard error. * denotes P ≤ 0.05 compared with
CON.
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Figure 10: Over-feeding during gestation alters offspring leucine, isoleucine, and valine
metabolism at multiple time points of gestation. Offspring metabolites involved in leucine,
isoleucine, and valine metabolism were altered in OVER compared with CON. LD collected
from offspring born to ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or
within 24 hours of birth (C) was analyzed by UPLC-MS/MS. Data are presented as fold change
± standard error. * denotes P ≤ 0.05 compared with CON.
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Figure 11: Over-feeding during gestation alters offspring tryptophan metabolism at
multiple time points of gestation. Offspring metabolites involved in tryptophan metabolism
were altered in OVER compared with CON. LD collected from offspring born to ewes fed CON,
RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was
analyzed by UPLC-MS/MS. Data are presented as fold change ± standard error. * denotes P ≤
0.05 compared with CON.
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Figure 12: Over-feeding during gestation alters offspring tyrosine metabolism at multiple
time points of gestation. Offspring metabolites involved in tyrosine metabolism were altered in
OVER compared with CON. LD collected from offspring born to ewes fed CON, RES, or OVER
diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was analyzed by UPLCMS/MS. Data are presented as fold change ± standard error. * denotes P ≤ 0.05 compared with
CON.
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Figure 13: Over-feeding during gestation alters offspring fatty acid and branched chain
amino acid metabolism at birth. Offspring metabolites involved in fatty acid and branched
chain amino acid metabolism were altered in OVER compared with CON. LD collected from
offspring born to ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within
24 hours of birth (C) was analyzed by UPLC-MS/MS. Data are presented as fold change ±
standard error. * denotes P ≤ 0.05 compared with CON.
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Figure 14: Over-feeding during gestation alters offspring fatty acid and acyl carnitine
metabolism at birth. Offspring metabolites involved in fatty acid and acyl carnitine metabolism
were altered in OVER compared with CON. LD collected from offspring born to ewes fed CON,
RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was
analyzed by UPLC-MS/MS. Data are presented as fold change ± standard error. * denotes P ≤
0.05 compared with CON.
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Figure 15: Over-feeding during gestation alters offspring lysophospholipid metabolism at
multiple time points of gestation. Offspring metabolites involved in lysophospholipid
metabolism were altered in OVER compared with CON. LD collected from offspring born to
ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth
(C) was analyzed by UPLC-MS/MS. Data are presented as fold change ± standard error. *
denotes P ≤ 0.05 compared with CON.
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Figure 16: Over-feeding during gestation alters offspring phosphatidylethanolamine
metabolism at multiple time points of gestation. Offspring metabolites involved in
phosphatidylethanolamine metabolism were altered in OVER compared with CON. LD collected
from offspring born to ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or
within 24 hours of birth (C) was analyzed by UPLC-MS/MS. Data are presented as fold change
± standard error. * denotes P ≤ 0.05 compared with CON.
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Figure 17: Restricted-feeding during gestation alters offspring glutamate metabolism at
multiple time points of gestation. Offspring metabolites involved in glutamate metabolism
were altered in RES compared with CON. LD collected from offspring born to ewes fed CON,
RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was
analyzed by UPLC-MS/MS. Data are presented as fold change ± standard error. * denotes P ≤
0.05 compared with CON.
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Figure 18: Restricted-feeding during gestation alters offspring glutathione metabolism at
multiple time points of gestation. Offspring metabolites involved in glutathione metabolism
were altered in RES compared with CON. LD collected from offspring born to ewes fed CON,
RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was
analyzed by UPLC-MS/MS. Data are presented as fold change ± standard error. * denotes P ≤
0.05 compared with CON.
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Figure 19: Restricted-feeding during gestation alters offspring histidine metabolism at
multiple time points of gestation. Offspring metabolites involved in histidine metabolism were
altered in RES compared with CON. LD collected from offspring born to ewes fed CON, RES,
or OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was analyzed by
UPLC-MS/MS. Data are presented as fold change ± standard error. * denotes P ≤ 0.05 compared
with CON.
84

Figure 20: Restricted-feeding during gestation alters offspring lysophospholipid
metabolism at multiple time points of gestation. Offspring metabolites involved in
lysophospholipid metabolism were altered in RES compared with CON. LD collected from
offspring born to ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within
24 hours of birth (C) was analyzed by UPLC-MS/MS. Data are presented as fold change ±
standard error. * denotes P ≤ 0.05 compared with CON.
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Figure 21: Restricted-feeding during gestation alters offspring phosphatidylcholine
metabolism at multiple time points of gestation. Offspring metabolites involved in
phosphatidylcholine metabolism were altered in RES compared with CON. LD collected from
offspring born to ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within
24 hours of birth (C) was analyzed by UPLC-MS/MS. Data are presented as fold change ±
standard error. * denotes P ≤ 0.05 compared with CON.
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Figure 22: Restricted-feeding during gestation alters offspring phosphatidylethanolamine
metabolism at multiple time points of gestation. Offspring metabolites involved in
phosphatidylethanolamine metabolism were altered in RES compared with CON. LD collected
from offspring born to ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or
within 24 hours of birth (C) was analyzed by UPLC-MS/MS. Data are presented as fold change.
* denotes P ≤ 0.05 compared with CON.
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Figure 23: Restricted-feeding during gestation alters offspring sphingolipid metabolism at
birth. Offspring metabolites involved in sphingolipid metabolism were altered in RES compared
with CON. LD collected from offspring born to ewes fed CON, RES, or OVER diets at d 90 (A),
135 (B) of gestation, or within 24 hours of birth (C) was analyzed by UPLC-MS/MS. Data are
presented as fold change ± standard error. * denotes P ≤ 0.05 compared with CON.
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DISCUSSION
When assessing the effects of poor maternal nutrition during gestation on offspring
development, many research groups focus on either restricted- (Vonnahme et al., 2003; Daniel et
al., 2007; Ford et al., 2007; Ge et al., 2013) or over-feeding (Zhu et al., 2008; Tong et al., 2009;
Caton et al., 2009; Long et al., 2010; Yan et al., 2011). Our model is unique since it allows for
comparison of both restricted- and over-nutrition at multiple time points during gestation (Pillai
et al., 2017). Additionally, the multiple prenatal and birth time points allow us to assess changes
to offspring development and metabolism over time. Restricted- and over-feeding can result in
similar phenotypic changes to the offspring, such as changes in CSA of muscle fibers (Reed et
al., 2014). However, the mechanisms behind these changes are often different, due to the
influence of the maternal diet (Hoffman et al., 2016). One mechanism that can promote these
changes is alterations to offspring metabolism (Hoffman et al., 2017). Previous studies have
determined that metabolism is a key factor that determines if a cell will proliferate, differentiate,
or remain quiescent (Ochocki and Simon, 2013; Shyh-Chang et al., 2013; Hu et al., 2016).
Energy metabolism and nutrient sensing help regulate stem cell function and tissue development
during gestation (Ochocki and Simon, 2013; Shyh-Chang et al., 2013; Hu et al., 2016). This is
especially important for muscle, since gestation is a critical window of development for skeletal
muscle formation and requires the coordinated progression of cell proliferation, cell cycle exit,
and differentiation (Braun et al., 2011).
Changes to the intrauterine environment and offspring metabolism in response to poor
maternal nutrition can alter the concentrations of hormones and growth factors, ultimately
affecting metabolism. Specifically, lambs exposed to under- and over-nutrition during gestation
demonstrated decreased serum concentrations of IGF1 and IGF binding protein 3 at birth
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(Hoffman et al., 2014). Further, at 3 mo of age, leptin concentrations were increased in offspring
from over-fed ewes compared with restricted-fed ewes (Hoffman et al., 2016). In the same study,
average insulin concentrations between birth and 3 mo of age were increased in offspring from
over-fed and restricted-fed ewes compared with controls (Hoffman et al., 2016). Exposure to
maternal undernutrition also altered glucose tolerance in the offspring (Ford et al., 2007).
Specifically, at d 63 of age, lambs from restricted-fed mothers had greater area under the curve
for glucose and insulin compared with controls. These changes to hormone and growth factor
concentrations have the potential to influence the formation and development of muscle fibers
during gestation (Baum et al., 1996; Sotiropoulos et al., 2006; Velloso et al., 2008).
Circulating factors and hormone concentrations can impact muscle fiber formation and
growth by increasing muscle mass and regulating fiber formation (Baum et al., 1996;
Sotiropoulos et al., 2006; Velloso et al., 2008). These circulating factors may also be influencing
the muscle phenotype by altering stem cell populations. Studies support that poor maternal
nutrition can negatively impact offspring stem cells. In mice, exposure to both maternal undernutrition and early postnatal over-nutrition decreased the number of skeletal muscle precursor
cells (Woo et al., 2011). In the absence of cultured skeletal muscle precursor cells from lambs,
C2C12 myoblasts can be used to assess how serum from offspring exposed to poor maternal
nutrition influences myoblast proliferation, differentiation, and metabolism. Despite evidence
which supports changes to hormones and growth factors in offspring serum in response to poor
maternal nutrition, serum collected at birth from offspring exposed to under- or over-nutrition
had no effect on myoblast proliferation, fiber fusion index, or fiber diameter. Other factors such
as genetics and epigenetics can regulate muscle development (Peñagaricano et al., 2014; Kalbe et
al., 2017). Many experiments demonstrate that poor maternal nutrition influences gene

91

expression in muscle. For example, Kalbe et al., (2017) found that exposure to maternal
increased and restricted protein diets altered the mRNA expression of myogenic regulatory
factors and IGFs. Another experiment demonstrated that maternal high-starch diet induces gene
expression changes in the skeletal muscle and adipose of lambs (Peñagaricano et al., 2014).
Specifically, genes involved in myogenic differentiation, glycolysis, gluconeogenesis, and the
insulin signaling pathway were differentially expressed (Peñagaricano et al., 2014). These
alterations to gene expression in response to poor maternal nutrition may be causing changes to
muscle development along with changes to hormone and growth factor concentrations in serum.
Additionally, the birth time point for serum collection may be a reason that there are no changes
to proliferation or differentiation. Many studies examine changes to hormone concentrations at
postnatal time points when the animal is more mature (Ford et al., 2007; Hoffman et al., 2014,
2016). Collecting serum from lambs exposed to poor maternal nutrition during gestation at later
time points may result in different findings.
In addition to assessing whether serum from offspring from over- and restricted-fed ewes
could influence C2C12 proliferation and differentiation, we analyzed whether the serum could
influence myoblast metabolism. The serum collected from offspring exposed to restricted
maternal diet altered the mitochondrial respiration of C2C12 myoblasts. Specifically, offspring
from restricted-fed ewes exhibited increased proton leak compared with controls. Proton
pumping across the mitochondrial membrane and proton leak contribute to a cycle that dissipates
redox energy (Rolfe et al., 1999). Additionally, the mitochondrial proton cycle contributes to
15% of the standard metabolic rate in skeletal muscle (Rolfe et al., 1999). Increased proton leak
could result in increased metabolic rate which could largely affect mitochondrial metabolism and
potentially decrease efficiency (Rolfe et al., 1999). Multiple studies have demonstrated that.
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caloric restriction decreases skeletal muscle proton leak (Bevilacqua et al., 2004; Bevilacqua et
al., 2005). This is of note because our study demonstrated contrary findings since C2C12
myoblasts cultured in serum from RES offspring had increased proton leak. However, this result
may be different if proton leak was measured in the mitochondria or in satellite cells isolated
from RES offspring. Others have shown that poor maternal nutrition during gestation can alter
metabolism in other stem cells (Pillai et al., 2016). Specifically, Pillai et al., (2016) reported that
restricted feeding decreased basal respiration, ATP production, and maximal respiration of
offspring mesenchymal stem cells compared with controls. Additionally, maternal over-feeding
decreased basal respiration, ATP production, maximal respiration, and spare-respiratory capacity
of offspring mesenchymal stem cells compared with controls. Although the variables altered
were different than in the present experiment, the data demonstrate that poor maternal nutrition
can alter stem cell metabolism in different cell populations. In mice, male offspring from obese
mothers had decreased mitochondrial complex II-III (Shelley et al., 2009). Another group
showed that pigs exposed in utero to high energy diets had decreased mitochondrial DNA
content and downregulated mRNA expression of genes associated with mitochondrial biogenesis
and function (Zou et al., 2016a). Further, moderate maternal dietary energy intake decreased
mitochondrial biogenesis (Zou et al., 2016b). Despite noted differences in mitochondrial
respiration in C2C12 myoblasts exposed to offspring serum, there were no changes to glycolytic
function. Similarly, poor maternal nutrition during gestation did not alter any of the variables
associated with glycolytic function in mesenchymal stem cells (Pillai et al., 2016). Therefore
poor maternal nutrition may be altering metabolism through changes to mitochondrial function.

Metabolome Analysis
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To better understand metabolic changes in muscle during gestation in response to poor
maternal nutrition, a metabolome analysis was conducted on LM samples from offspring of
control-fed, restricted-fed, and over-fed dams at d 90, d 135, and birth time points. Metabolome
analysis demonstrated that both maternal diet and day of gestation drive changes to LM
metabolism, including changes to amino acid, lipid, carbohydrate, and energy metabolism. The
principle component analysis indicates that samples within each developmental time period (d
90, d 135, birth) exhibit close overlapping grouping, indicative of an overall similar metabolite
composition. This suggests that the stage of development is a more powerful driver of
metabolism than maternal nutrition. This is not unexpected given the vast changes in fetal
muscle metabolism during gestation. Birth represents a switch in nutrient utilization and
metabolism (Girard, 1990; Hillman, et al., 2012). The fetal diet is rich in carbohydrates supplied
from the mother and poor in fat. In the fetus, gluconeogenesis and ketogenesis are absent or very
low. At birth, the maternal glucose supply is removed and the diet becomes more reliant on lipids
and less reliant on carbohydrates (Girard, 1990). Because of this, there are drastic changes to
energy metabolism, with gluconeogenesis and ketogenesis becoming more active within 24 h of
birth (Girard, 1990; Hillman et al., 2012). In our study, metabolome analysis demonstrated a
similar shift in nutrient utilization between the fetus and postnatal animal.

Maternal over-nutrition during gestation alters offspring LM metabolome at d 90
At d 90 of gestation, offspring from over-fed mothers exhibited altered amino acid
metabolism compared with controls demonstrated by changes to alanine and aspartate
metabolism, tyrosine metabolism, tryptophan metabolism, histidine metabolism, and leucine,
isoleucine and valine metabolism. Amino acid sensing can regulate myogenesis through the
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mammalian target of rapamycin (mTOR) pathway (Mee-Sup and Chen, 2013). The mTOR
pathway is a key regulator of skeletal myogenesis and regulates different steps of differentiation
(Ge and Chen, 2012). Multiple studies indicate that amino acids work upstream in the mTOR
signaling pathway and can serve to activate signaling through the pathway, resulting in increased
protein synthesis (Sancak et al., 2008, Ma and Blenis, 2009, Sancak et al., 2010; Bar-Peled et al.,
2012, Bar-Peled et al., 2013). Therefore, these early changes to amino acid metabolism,
especially leucine metabolism, may play a part in regulating myogenesis.
Offspring of over-fed dams also exhibited changes to glutathione metabolism, including
increased reduced glutathione (GSH) and decreased cysteine-glutathione disulfide and 2aminobutyrate. However, the oxidized glutathione (GSSG) was similar to control. Changes to
glutathione metabolism could be indicative of changes in redox status and oxidative stress. The
GSH:GSSG ratio can be used as a marker of oxidative stress, and changes to this ratio are
indicative of changes in redox status (Zitka et al., 2012). Therefore, follow up analysis of
markers of oxidative stress and/or antioxidants in the muscle would further define the redox
status in the offspring and the response to poor maternal nutrition.
Maternal over-feeding also resulted in perturbations to branched-chain amino acid
(BCAA) catabolism. Offspring from over-fed ewes exhibited divergent branched-chain amino
acid catabolism compared with controls. Specifically, LM from offspring of over-fed mothers
exhibited accumulation of three key intermediates of BCAA breakdown, betahydroxyisovalerate, 3-methylglutaconate, and 3-hydroxyisobutyrate at both d 90 and 135 that
indicate increased BCAA catabolism. This may reflect increased support for muscle energy
production since the complete oxidation of the BCAAs in the mitochondria efficiently allows
formation of ATP by oxidative phosphorylation (Brosnan and Brosnan, 2006). Less likely,
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gluconeogenesis can also be supported, as the end-products of the pathway (succinyl CoA and
acetyl CoA) can support both of these processes (Shimomura et al., 2004; Brosnan and Brosnan,
2006; Tao et al., 2017).

Maternal over-nutrition during gestation alters offspring LM metabolome at d 135
Similar to d 90, the most abundant metabolite changes at d 135 were to amino acid
metabolism, including alanine and aspartate metabolism, N-acetylaspartate (NAA) metabolism,
branched chain amino acid metabolism, and histidine metabolism. N-acetylaspartate is
synthesized from aspartate and acetyl-CoA by aspartate N-acetyltransferase (Bogner-Strauss,
2017). It can then be cleaved by aspartoacylase to generate aspartate and acetate. Acetyl-CoA
synthetase uses acetate to generate acetyl-CoA, a general energy metabolite and second
messenger with roles in lipid synthesis (Bogner-Strauss, 2017). For histidine, imidazole
propionate and formiminoglutamate, products of histidine catabolism, were increased compared
with controls. There were also increases in metabolites involved in leucine, isoleucine and valine
metabolism at d 135 compared with controls. Leucine, isoleucine, and valine are branched chain
amino acids and are essential to muscle metabolism since they can be used as energy sources and
are necessary for protein synthesis in the muscle (Wagenmakers et al., 1998). Branched chain
amino acids stimulate protein synthesis and are required for mTOR regulation of myogenesis
(Yoon et al., 2017). This pathway is essential for muscle hypertrophy and maintaining muscle
mass (Yoon et al., 2017). At d 135, the muscle is no longer going through the primary and
secondary waves of myogenesis, but instead starting to hypertrophy. Therefore, alterations to
amino acid metabolism could negatively affect protein synthesis and skeletal muscle hypertrophy
(Du et al., 2010).
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Maternal over-nutrition during gestation alters offspring LM metabolome at birth
Over-feeding during gestation altered the lipid metabolism in the offspring at birth.
Specifically, increased maternal nutrient consumption induces apparent lipid oxidation in the
lambs. There was an increase in the ketogenic marker 3-hydroxybutyrylcarnitine at birth in
offspring from over-fed mothers. This is associated with a decrease in short and long chain
acylcarnitines. Carnitines shuttle long-chain fatty acids into the mitochondria where they are
used to generate ATP (McGarry et al., 1975; Parvin and Pande 1978). They serve as substrates in
branched chain amino acid metabolism and provide readouts for β-oxidation (McGarry et al.,
1975; Parvin and Pande 1978). In general, ketogenesis increases when the rate of liver fatty acid
β-oxidation exceeds the TCA cycles capacity to use acetyl-CoA. Ketogenesis frequently occurs
under conditions of nutrient deprivation and high circulating free fatty acids (McGarry et al.,
1975; Parvin and Pande 1978). Thus, changes to acylcarnitines in the LM of OVER offspring
may reflect a mechanism to utilize excess β-oxidation intermediates. Corresponding depletion of
glycolytic intermediates dihydroxyacetone phosphate (DHAP) and phosphoenolpyruvate (PEP)
indicate reduced carbohydrate oxidation in favor of lipid utilization. During lipid synthesis,
DHAP provides adipose cells with the activated glycerol backbone required to synthesize new
triglyceride. Taken together with the depletion of polyunsaturated fatty acid concentrations of
docosapentaenoate (n3 DPA; 22:5n3) and eicosapentaenoate (EPA; 20:5n3), this suggests a shift
away from lipogenesis to increased lipid oxidation in offspring from over-fed mothers, relative to
controls.
The lipid oxidation profile in offspring from over-fed mothers is also associated with
cellular membrane degradation. Decreased concentrations of muscle phosphatidylcholines (PC)
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and phosphatidylethanolamines (PE), including 1-linoleoyl-2-linolenoyl-GPC (18:2/18:3)* and
1-oleoyl-2-linoleoyl-GPE (18:1/18:2)* were identified compared with control offspring at birth.
These lipids are key components of the plasma membrane and their depletion may represent
increased membrane turnover (Van der Veen et al., 2017). A similar profile is produced in
offspring of restricted-fed mothers that largely involves a distinct subset of PC, including 1palmitoyl-2-palmitoleoyl-GPC (16:0/16:1)*. Because these lipids are comprised of similar FA
speciation, these decreases are likely associated with membrane degradation, relative to control
animals, as both groups respond to changes in maternal diet.
Over-feeding during gestation also resulted in changes to the offspring lysolipid pool.
Lambs from over-fed mothers exhibited depletion in the lysolipid pool at birth, compared with
control offspring. The majority of the altered phospholipids are ethanolamine and choline
derivatives (e.g. 1-palmitoleoyl-GPE (16:1)*, 1-palmitoyl-GPE (16:0), 1-linoleoyl-GPC (18:2),
and 1-arachidonoyl-GPE (20:4n6)*) that are enriched on the inner and outer leaflets of the
plasma membrane, respectively. Lysolipids, as well as fatty acids, are the natural products
formed by the hydrolysis of phospholipids and may represent membrane remodeling related to
phospholipid lysis (Arouri and Mouritsen, 2013). Collectively, offspring of over-fed dams
exhibit potently increased β-oxidation, particularly at birth. This is of note since increased βoxidation in muscle cells is associated with enhanced insulin-stimulated glucose metabolism and
also protects against fatty acid-induced insulin resistance (Perdormo et al., 2004). The increased
β-oxidation could be a potential response to increased maternal nutrition.

Maternal restricted-feeding during gestation alters offspring LM metabolome at d 90
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At d 90, one of the most apparent changes in response to maternal restricted-nutrition was
alterations to sphingolipid metabolism. Seventeen metabolites involved in sphingolipid
metabolism were reduced compared with CON. Sphingolipids are an essential part of cellular
lipid membranes and also serve as second messengers for signal transduction in pathways
affecting cell growth, differentiation, stress responses, and death (Merrill et al., 1997; Khavander
and Murshed, 2015). Sphingolipids play a role in the regulation of skeletal muscle development
and tissue homeostasis (Stoffel, 1999; Aubin et al., 2005; Khavander et al., 2011, 2013;
Khavander and Murshed, 2015). The broad changes to sphingolipid metabolism demonstrate the
early effects of maternal restricted-nutrition on muscle development.
Additionally, there are changes to glutathione metabolism at d 90 in the offspring from
restricted-fed mothers. Similar to OVER offspring at this time-point, GSH is increased 3.1-fold
and 2-aminobutyrate is decreased, again suggesting changes in redox status. This could have
potential negative effects on muscle metabolism. For example, oxidative stress has been shown
to reduce insulin-stimulated glucose transport and insulin signaling in insulin-sensitive cells such
as L6 myocytes (Maddux et al., 2001; Rudich et al., 1997; Rudich et al., 1998). Thus, there is
potential for altered redox status to result in impaired insulin action and altered metabolism
within the muscle.

Maternal restricted-feeding during gestation alters offspring LM metabolome at d 135
In RES offspring at d 135, amino acid metabolism, including histidine, branched chain
amino acids, glutamate, tyrosine and tryptophan were altered compared with CON. Of particular
interest is the reduction of glutamate in RES offspring compared with CON. Glutamate is
essential for protein synthesis in the body (Walker and Van der Donk, 2016), but also has an
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important role in muscle metabolism (Rennie et al., 1995). Muscle glutamate concentrations are
correlated with muscle glutathione concentrations, and glutamate plays a determining role in
glutathione synthesis (Amores-Sanches and Medina 1999; Engelen et al., 2000; Rutten et al.,
2005). The reduction in glutamate concentrations at d 135 is of note since it corresponds with
changes to glutathione metabolism at this time point. Specifically, GSSG is reduced and 2aminobutyrate is increased in RES compared with CON. The reduction in glutamate may be one
of the mechanisms promoting the change to glutathione metabolism, and therefore redox status,
at this time point.

Maternal restricted-feeding during gestation alters offspring LM metabolome at birth
Restricted maternal feeding additionally altered offspring pyrimidine metabolism at birth.
Pyrimidine intermediates provide important substrates for a wide array of lipids required for
membrane synthesis and may provide insight into the apparently distinct lipid oxidation profiles
(Berlin and Oliver, 1975; Lane and Fan, 2015). Here, there was an observed reduction in a
number of pyrimidine derivatives, including uridine, cytidine, and cytidine diphosphate (CDP).
Corresponding accumulation of pyrimidine biosynthesis marker orotate, with associated
depletion of pyrimidine degradation markers β-alanine and 3-aminoisobutyrate, suggests
increased pyrimidine synthesis. At this time point, there are also decreases to PC and PE pools.
This could indicate decreased membrane synthesis, particularly in muscle tissue from offspring
of mothers fed a restricted diet. Taken together with the changes to pyrimidine synthesis, this
indicates that restricted-feeding may promote attenuated membrane and lipid synthesis, instead
perhaps favoring anabolic reactions that favor pyrimidine synthesis.
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Offspring from restricted-fed mothers also exhibit increased concentrations of the
ketogenic marker 3-hydroxybutyrylcarnitine without associated significant changes in other
lipids. Ketone bodies play an important role in the adaptation to fasting, serving as an important
fuel for energy (Puckalska and Crawford, 2017). This increase in 3-hydroxybutyrylcarnitine at
birth could point to changes in energy utilization within the muscle and a potential for ketosis
postnatally. Offspring from restricted-fed mothers also exhibited changes to PC and PE
metabolism, and decreased concentrations of lysolipids, providing some evidence for membrane
turnover in these offspring. Again this demonstrates that RES offspring show changes to
membrane lipids and lipid oxidation at birth.
Maternal nutrient restriction also promotes changes in offspring cholate metabolism.
Prenatal caloric restriction results in reduced plasma bile acids in offspring mice, correlating with
low birth weight, glucose intolerance, and obesity (Ma et al., 2017). In the current study, we
observe divergent changes in cholate and a number of cholate bile salts, including taurocholate,
and deoxycholate at d 90 in muscle tissue from both RES and OVER offspring. With no obvious
changes in cholesterol metabolism, these changes likely do not reflect alterations in bile salt
synthesis, but rather dietary influences that may alter nutrient utilization by the intestine. Further,
there is evidence of perturbed enterohepatic circulation in the restricted group given increases in
primary bile salts (e.g., glycochenodeoxycholate, taurochenodeoxycholate, and glycocholate),
but decreased concentrations of secondary bile salts, particularly taurodeoxycholate. Briefly,
primary bile acids are conjugated with either taurine or glycine to decrease toxicity and increase
solubility. In the intestine, a portion of the bile acids could become deconjugated or modified to
form secondary bile acids which are reabsorbed by enterohepatic circulation. Decreased muscle
concentrations of secondary bile salts may reflect impairment of this process in the restricted
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state and possible suggest alterations in fetal or maternal liver function (Joyce et al., 2011). This
can have a significant impact on body weight gain and growth responses, as shown in a recent
murine model (Joyce et al., 2011).
Conclusion
Although the day of gestation had a greater effect on metabolic change than the
experimental feeding groups, analysis of the LM metabolome indicated that poor maternal
nutrition alters muscle metabolism. Muscle tissue from offspring of over-fed mothers exhibited
evidence of increased lipid oxidation accompanied by increased membrane turnover. Fetuses of
over- and restricted-fed mothers demonstrated altered amino acid utilization which may result in
changes to protein synthesis affecting muscle hypertrophy. Additionally, over- and restrictedfeeding also led to altered muscle concentrations of cholate during development. Offspring from
restricted-fed mothers demonstrated increased utilization of short chain fatty acids and increased
pyrimidine anabolism at birth. Restricted maternal nutrition may impair enterohepatic circulation
of bile salts in the offspring, which can have a profound impact on glucose tolerance and
development. However, further analysis of tissues such as the liver or serum from offspring may
give a clearer picture of changes to bile salts. Finally, offspring from both over- and restrictedfed ewes demonstrated altered glutathione metabolism at multiple time points, which could
indicate altered redox status, and possible oxidative stress.

Future Directions
Although the metabolome data gave a detailed picture of metabolic change in response to
maternal diet and day of gestation, further analysis on muscle tissue will provide additional
insight. Specifically, alterations in glutathione metabolism suggest the need for additional
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measures of redox status and oxidative stress. Additionally, the broad changes to lipid
metabolism in response to maternal diet, especially at birth, indicate that histological analysis of
lipid content within the muscle tissue may be warranted. Another area of interest is mTOR
signaling since this pathway is partially regulated by amino acid sensing. The metabolome
analysis indicated broad changes to amino acid metabolism in both treatment groups. Therefore,
there is potential for mTOR to be affected. Analysis of the mTOR pathway could determine if
the changes to amino acids are actually influencing mTOR regulation of protein synthesis.
Overall, further analysis of the muscle tissue would support the metabolome findings and
provided a more detailed understanding of how poor maternal nutrition during gestation is
affecting muscle development and metabolism.
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APPENDIX 1
Staining Protocol for Myosin Heavy Chain

First Day:
1. Remove cells from incubator
2. Remove media
3. Fix wells with 4% paraformaldehyde for 15 minutes
4. Rinse 2x with PBS
5. Add blocking solution for 20 minutes
•

0.2% Triton-X and 5% horse serum in PBS

6. Add primary antibody
•

MF20 at a dilution of 1:100

7. Let sit overnight in the dark (wrapped in tinfoil) in the 4C fridge

Next Day:
1. Rinse 2x with PBS
2. Add secondary antibody for 1 hour
•

488 goat-anti-mouse antibody at a dilution of 1:250

•

Hoescht 1:1000 to visualize nuclei

•

Keep in dark

3. Rinse all wells with PBS 2x
4. Image same day
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APPENDIX 2
Seahorse XF Cell Mito Stress Test Kit Protocol

* Plate cells 24 or 48 hours before assay at correct density depending on experimental protocol
C2C12 cells were plated at a density of 15,000 cells/ well and allowed to proliferate for 48 hours

Day prior to Assay
1. Plate cells at previously determined optimized density in the Seahorse XF Cell Culture
Microplate using the appropriate cell culture medium.
2. Hydrate a sensor cartridge in Seahorse XF Calibrant at 37oC in a non-CO2 incubator
overnight.

Day of the Assay
Prepare Assay Medium
1. Turn on Seahorse XF analyzer at least one hour before beginning experiment and allow
the machine to warm up and stabilize.
2. Prepare assay medium by supplementing Seahorse XF Base Medium with1 mM
pyruvate, 2 mM glutamine, and 10 mM glucose as a starting point. However, desired
medium concentration can be varied depending on cell type or in vitro culture conditions.
3. For 100 mL media add 1 mL pyruvate, 29.28 mg L-glutamine, and 0.4 mL glucose
4. Warm assay medium to 37oC.
5. Adjust pH to 7.4 with 0.1 N with NaOH.
6. Keep at 37oC until ready to use.
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Prepare Stock Compounds
Note: Use compounds the same day they are reconstituted. Do not refreeze. Discard any
remaining compound.
1. Prepare compounds using constant volume method provided in manual
2. Remove foil pouch from Seahorse XF cell Mito Stress Test Kit box. Each pouch contains
reagents sufficient for one Seahorse XF Cell Mito Stress Test in a 24 well Seahorse XF
Cell Culture Microplate.
3. Open pouch and remove the three tubes containing oligomycin (blue cap), FCCP (yellow
cap), and rotenone/ antimycin A (red cap). Place tubes in small tube rack.
4. Re-suspend contents of each tube with prepared assay medium in volumes described in
Table 2 of provided booklet with a pipette. Gently pipette up and down (~10 times) to
solubilize compounds.
5. Prepare 3 mL of each compound in assay medium. Seahorse recommends using 1 uM of
oligomycin for most cells.

Load Sensor cartridge
1. Standard assay – no additional injection:
•

Load compounds into the appropriate ports of a hydrated sensor cartridge for each
well (75 µL per port)
o Port A: Oligomycin
o Port B: FCCP
o Port C: Rotenone/ antimycin A
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Prepare Seahorse XF Culture Microplate for Assay
1. Remove cells from culture microplates from the 37oC CO2 incubator and examine cells
under the microscope to confirm confluence.
2. Remove assay medium from water bath.
3. Change the cell culture growth medium I the cell culture microplate to warmed assay
medium using a multichannel pipette and place the cell culture microplate into a 37oC
non-CO2 incubator for 45 minutes to 1 hour prior to the assay.

Run the Seahorse XF Mito Stress Test
•

Open Wave and create new procedure file. Follow the instructions below:
1. Design new experiment in wave
▪

Add oligomycin, FCCP, and Rotenone/ Anitmycin-A to injection ports

▪

Add treatment groups and add to plate map

2. Select the “Review and Run” tab, then click “Start Run”.
3. When prompted, place the loaded sensor cartridge with the calibrant plate into the
instrument, then click “I’m ready”. Calibration will take approximately 15-30
minutes. Note: remove cartridge lid and verify correct plate orientation.
4. Following calibration and equilibration of the cell culture microplate, when
prompted click “I’m ready”. Load the cell culture microplate and click “I’m
ready” to run the assay.
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Data Analysis
•

The Seahorse XF Mito Stress Test Report Generator automatically calculates the
Seahorse XF Cell Mito Stress Test parameters from Wave data that has been exported to
Excel. It can be used either with standard or modified stress test protocol and provides
convenient, customizable one-page assay summary. The Report Generator can be
installed either alongside Wave or directly from the Seahorse Bioscience website.

•

Next day: Isolate DNA from each well to normalize data using the Macherey-Nagel
NucleoSpin Tissue Kit (50 preps; Ref #740952.50) according to manufacturer
instructions
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APPENDIX 3
Seahorse XF Cell Glycolysis Stress Test Kit Protocol

*Plate cells 24 or 48 hours before assay at correct density depending on experimental protocol
C2C12 cells were plated at a density of 15,000 cells/ well and allowed to proliferate for 48 hours

Day prior to Assay
1. Plate cells at previously determined optimized density in the Seahorse XF Cell Culture
Microplate using the appropriate cell culture medium.
2. Hydrate a sensor cartridge in Seahorse XF Calibrant at 37oC in a non-CO2 incubator
overnight.

Day of the Assay
Prepare Assay Medium
1. Turn on Seahorse XF Analyzer at least one hour before experiment and let it warm up to
stabilize.
2. Prepare assay medium by supplementing Seahorse XF Base Medium with 1 mM
glutamine as a starting point.
3. For 100 mL media add 14.6 mg L-glutamine.
4. Warm assay medium to 37oC.
5. Adjust pH to 7.4 with 0.1 N with NaOH.
6. Keep at 37oC until ready to use.
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Prepare Stock Compounds
Note: Use compounds the same day they are reconstituted. Do not refreeze. Discard any
remaining compound.
1. Prepare compounds using constant volume method described in provided manual
2. The Seahorse XF Glycolysis Stress Test Kit Includes 6 foil pouches each containing
oligomycin, 6 vials containing glucose, and 6 vials containing 2-DG. The kit reagents are
sufficient for 6 XF Glycolysis Stress Test assay in a 24-well Seahorse XF Cell Culture
Microplate.
3. Open foil pouch containing oligomycin (light blue cap) and remove 1 vial containing
glucose (blue cap) and 1 vial containing 2-DG (green cap) from the kit box.
4. Re-suspend each component with prepared assay medium in volumes described in 3 with
p1000 pipette. Gently pipette up and down (~10 times) to solubilize the compounds.
Vortex the 2-DG to ensure that it goes into solution.

Load Sensor cartridge
1. Standard assay – no additional injection:
•

Load compounds into the appropriate ports of a hydrated sensor cartridge for each
well (75 µL per port)
o Port A: Glucose
o Port B: Oligomycin
o Port C: 2-DG
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Prepare Seahorse XF Culture Microplate for Assay
1. Remove cells from culture microplates from the 37oC CO2 incubator and examine cells
under the microscope to confirm confluence.
2. Remove assay medium from water bath.
3. Change the cell culture growth medium I the cell culture microplate to warmed assay
medium using a multichannel pipette and place the cell culture microplate into a 37oC
non-CO2 incubator for 45 minutes to 1 hour prior to the assay.

Run the Seahorse XF Glycolysis Stress Test
•

Open Wave and create new procedure file. Follow the instructions below:
1. Design new experiment in wave
▪

Add glucose, oligomycin, and 2-DG to injection ports

▪

Add treatment groups and add to plate map

2. Select the “Review and Run” tab, then click “Start Run”.
3. When prompted, place the loaded sensor cartridge with the calibrant plate into the
instrument, then click “I’m ready”. Calibration will take approximately 15-30
minutes. Note: remove cartridge lid and verify correct plate orientation.
4. Following calibration and equilibration of the cell culture microplate, when
prompted click “I’m ready”. Load the cell culture microplate and click “I’m
ready” to run the assay.
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Data Analysis
•

The Seahorse XF Glycolysis Stress Test Report Generator automatically calculates the
Seahorse XF Cell Mito Stress Test parameters from Wave data that has been exported to
Excel. It can be used either with standard or modified stress test protocol and provides
convenient, customizable one-page assay summary. The Report Generator can be
installed either alongside Wave or directly from the Seahorse Bioscience website.

•

Next day: Isolate DNA from each well to normalize data using the Macherey-Nagel
NucleoSpin Tissue Kit (50 preps; Ref #740952.50) according to manufacturer
instructions
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